CA1124943A - Synthetic absorbable surgical devices of poly-dioxanone - Google Patents
Synthetic absorbable surgical devices of poly-dioxanoneInfo
- Publication number
- CA1124943A CA1124943A CA269,401A CA269401A CA1124943A CA 1124943 A CA1124943 A CA 1124943A CA 269401 A CA269401 A CA 269401A CA 1124943 A CA1124943 A CA 1124943A
- Authority
- CA
- Canada
- Prior art keywords
- polymer
- dioxanone
- suture
- weight
- absorbable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/66—Polyesters containing oxygen in the form of ether groups
- C08G63/664—Polyesters containing oxygen in the form of ether groups derived from hydroxy carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
- A61B17/06166—Sutures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
- A61L17/06—At least partially resorbable materials
- A61L17/10—At least partially resorbable materials containing macromolecular materials
- A61L17/105—Polyesters not covered by A61L17/12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00004—(bio)absorbable, (bio)resorbable, resorptive
Abstract
ABSTRACT OF THE DISCLOSURE
Synthetic absorbable sutures and other surgical devices are prepared from polymers of p-dioxanone and 1,4-dioxepan-2-one, and alkyl substituted derivatives thereof.
Monofilament sutures of oriented fibers are characterized by good tensile and knot strength and a high level of flexibility and softness. The sutures have good in vivo strength retention and are slowly absorbed without significant tissue reaction.
Synthetic absorbable sutures and other surgical devices are prepared from polymers of p-dioxanone and 1,4-dioxepan-2-one, and alkyl substituted derivatives thereof.
Monofilament sutures of oriented fibers are characterized by good tensile and knot strength and a high level of flexibility and softness. The sutures have good in vivo strength retention and are slowly absorbed without significant tissue reaction.
Description
llZ49~3 This invention relates to synthetic absorbable sutures, and more particularly, to synthetic absorbable sutures comprising extruded and oriented filaments of polymers of p-dioxanone or l,4-dioxepan-2-one.
Absorbable suture materials have traditionally been natural collagenous materials obtained from sheep or beef intestine, commonly known as catgut. More recently, it has been proposed to manufacture synthetic absorbable sutures from polyesters of hydroxycarboxylic acids, notably polylactide, polyglycolide, and copolymers of lactide and glycolide, Such synthetic absorbable sutures are described in USP 3,636,956, 3,297,033 and elsewhere in the literature, Among the requirements of an ideal absorbable suture are that it should have good handling properties, should approximate and hold tissue for proper healing with minimal tearing and tissue damage, should have adequate straight tensile and knot strength, should be controllably uniform in properties including dimensional stability within the body, should be sterilizable, should be absorbable by living tissue, preferably at a constant rate regardless of the place in the body or the condition of the patient, with-out causing such unfavorable tissue reactions as walling off, granuloma formation, excessive edema, etc., and finally should be capable of being properly and easily tied into surgical knots.
~ nile multifilament sutures manufactured from polymers of lactide and glycolide fulfill the above require-ments to a large degree, monofilament sutures of these materials are considerably less flexible than catgut and these synthetic sutures are accordingly generally limited llZ4943 to a multifilament, braided construction. Sutures of glycolide polymers are also not suitable for sterilization by radiation without suffering severe degradation of physical properties.
The present invention provides synthetic absorbable sutures having a high degree of softness and flexibility which allows the sutures to be used in monofilament form. The sutures can also be sterilized with cobalt 60 radiation with-out serious loss of suture strength. It is accordingly an object of the present invention to provide synthetic absorb-able sutures having unique and desirable properties not available with the sutures of the prior art.
We have discovered that polymers of p-dioxanone and 1,4-dioxepan-2-one prepared from monomers of very high purity can be melt extruded into pliable, monofilament fibers which are slowly absorbed in animal tissue without significant ad-verse tissue reaction. The fibers have good tensile and knot strength and good in vivo strength retention, and can be sterilized with cobalt 60 without serious loss of these properties.
Polymers of p-dioxanone and fibers extruded there-from have been known in the art. USP 3,063,967 and '968 for example, describe the polymerization of p-dioxanone and the preparation of films and fibers therefrom. The low tensile strength of fibers prepared in accordance with the teachings of these references, however, make these fibers generally unsuitable for use as surgical sutures. Moreover, there was no appreciation in these references of the absorbability of such fibers which were reported to be resistant to the effects of saline and distilled water.
llZ4943~
Other references dealing with the polymerization of p-dioxanone include, but are not limited to, USP 3,190,858, 3,391,126 and 3,645,941 which disclose various catalysts for the polymerization of lactones such as p-dioxanone, and USP
3,020,289 which describes the polymerization of p-dioxanone in the presence of sulfuric acid. None of these references suggest polymers of p-dioxanone or l,4-dioxepan-2-one for use in the preparation of synthetic absorbable sutures in accor-dance with the present invention.
In one aspect of the present invention there is provided a sterile, synthetic absorbable suture comprising oriented fiber of a polymer of a monomer having the formula:
R--ICH ~1--O
~ O ~
wherein R' and R are individually hydrogen, methyl or ethyl, said suture being dry to the extent of being substantially free of moisture, and characterized by a Young's modulus of less than about 600,000 psi with a correspondingly high degree of softness and flexibility, an initial straight tensile and knot strength of at least about 40,000 psi and 30,000 psi respectively, and substantially complete absorption in vivo within about 180 days.
In a further aspect of the present invention there is provided a sterile synthetic absorbable suture comprising oriented fiber of a polymer having units of the formula:
~lZ4~3 ~ 0 R' R Rl l t C- CH- 0--C- CH- 0-~ -R x wherein R' and R are individually hydrogen, methyl, or ethyl and x is the degree of polymerization resulting in a fiber forming polymer, said suture being dry to the extent of being substantially free of moisture, and characterized by a Young's modulus of less than about 600,000 psi with a correspondingly high degree of softness and flexibility, an initial straight tensile and knot strength of at least about 40,000 psi and 30,000 psi respectively, and substantially complete absorption in vivo within about 180 days.
In a further aspect of the present invention there is provided a surgical prosthesis comprising a fabric manufactured at least in part from synthetic absorbable fibers of a polymer having units of the formula:
R~ IR R
C -CH- 0- f_ CH- 0 R x wherein R' and R are individually hydrogen, methyl, or ethyl and x is the degree of polymerization resulting in a fiber forming polymer, said fibers being dry to the extent of being substantially free of moisture, and characterized by a Young's modulus of less than about 600,000 psi with a correspondingly high degree of softness and flexibility, an initial straight tensile and knot strength o~ at least about 40,000 psi and -3a-~49~3 30,000 psi respectively, and substantially complete absorption in vivo within about 180 days.
In a further aspect of the present invention there is provided a surgical prosthesis comprising a solid surgical aid formed from an absorbable polymer having units of the formula:
R' R R
C- CH- 0- f CH- 0 R x wherein R' and R are individually hydrogen, methyl, or ethyl and x is the degree of polymerization resulting in a fiber forming polymer, said prosthesis being dry to the extent of being substantially free of moisture.
In a further aspect of the present invention there is provided a method of closing a wound in living tissue which comprises approximating the edges of the wound with a synthetic absorbable suture consisting of at lea.,t one filament of a polymer of a monomer having the formula:
~0~
R-fH 1=
~ O ~
wherein R' and R are individually hydrogen, methyl or ethyl, said suture being at least partially embedded in the living tissue, and leaving said suture in said tissue until the em-bedded suture is absorbed during the healing process, said suture being characterized by a Young's modulus of less than about 600,000 psi with a correspondingly high degree of softness -3b-~,~
.i. ~, ll~g~4~
and flexibility, an initial straight tensile and knot strength of at least about 40,000 psi and 30,000 psi respectively, and substantially complete absorption in ~ivo within about 180 days.
In a further aspect of the present invention there is provided a method of closing a wound in living tissue which comprises approximating the edge of the wound with a synthetic absorbable suture consisting of at least one filament of a polymer having units of the formula:
O R' R R
_ -C- CH- O- C -CH- O- _ . R x wherein R' and R are individually hydrogen, methyl or ethyl, and x is the degree of polymerization resulting in a fiber forming polymer, said suture being at least partially embedded in the living tissue, and leaving said suture in said tissue until the embedded suture is absorbed during the healing process, said suture being characterized by a Young's modulus of less than about 600,000 psi with a correspondingly high degree of softness and flexibility, an initial straight tensile and knot strength of at least about 40,000 psi and 30,000 psi respectively, and substantially complete absorption in vivo within about 180 days.
DESCRIPTION OF DRAWINGS
FIGURE 1 is a perspective view of a needle-suture combination, FIGURE 2 is a perspective view o a suture-needle combination within a hermetically sealed container' FIGURE 3 illustrates a screw machined from the polymer of the present invention;
FIGURE 4 is a cross-sectional view of a composite yarn containing filaments of different composition and, FIGURE 5 is a plan view of a surgical fabric knitted from fibers of the present invention.
Polymers of the present invention are comprised of units having the general formula:
O R' fi R
_ - C - CH- t C ~ CH - - X
wherein R' and R are individually hydrogen, methyl, or ethyl, n is 1 or 2 provided that when n is 2 at least two R groups are hydrogen, and x is the degree of polymerization resulting in a fiber forming polymer.
The polymer is conveniently prepared from highly purified monomer, i.e., monomer of at least about 98 percent purity, having the formula:
R-CH \ C=O
(R-C-R)n HC-R' \0/
wherein R, R' and n are as defined above. When n is 1, the monomer is preferably p-dioxanone, methyl-p-dioxanone, or di-methyl-p-dioxanone. When n is 2, the monomer is prefer-ably 1,4-dioxepan-2-one.
A particularly preferred monomer is p-dioxanone, and the following description and examples which are presented by way of illustration are directed primarily to the ~lZ4943 .
preparation and polymerization of that monomer, it being understood that certain variations may apply to other monomers and polymers encompassed by the above formula as will be readily apparent to those skilled in the art. Para-dioxanone monomer is conveniently prepared by reacting ethylene glycol, metallic sodium, and chloroacetic acid as hereinafter des-cribed in detail. m e resulting monomer is preferably purified to 99+% purity by multiple distillations and re-crystallizations, We have discovered that high monomer purity is necessary to obtain a high molecular weight polymer and ultimately, a fiber of good tensile and dry knot strength.
The purified monomer is polymerized at a tempera-ture of 20 to 130C, most preferably above 75C, in the presence of an organometallic catalyst as hereinafter des-cribed in detail to obtain a high molecular weight polymer of p-dioxanone characterized by an inherent viscosity of at least about 0.50 measured as a 0.1% solution in tetra-chloroethane at 25C, and a crystallinity of at least about 20% as determined by X-ray diffraction.
me polymer is melt extruded through a spinneret in a conventional manner to form one or more filaments which are subsequently drawn about 4x to 6x in order to achieve molecular orientation and improve tensile properties. The resulting oriented filaments have good tensile and dry knot strength and good in vivo strength retention.
To further improve dimensional stability and tensile strength retention, the oriented filaments may be subjected to an annealing treatment. This optional annealing treatment consists of heating the filaments to a temperature of from about 50 to 105C, most preferably from about 50 to 80C
while restraining the filaments to prevent any substantial '~' llZ4943 shrinkage, The filaments are held at the annealing temper-ature for a few seconds to several days or longer depending on the temperature and processing conditions, In general, annealing at 50 to 80C for up to about 24 hours is satis-factory for p-dioxanone, Optimum annealing time and temper-ature for maximum improvement in fiber in vivo strength retention and dimensional stability is readily determined for each fiber composition, Since the function of a suture is to join and hold severed tissue until healing is well along, and to prevent separation as a result of movement or exercise, a suture must meet certain minimum standards of strength, It is particularly important that strength be maintained when knots are tied and during the actual procedure of drawing tight a suitable knot, Oriented filaments of the present invention are characterized by a straight tensile strength of at least about 40,000 psi and a knot strength of at least about 30,000 psi, although significantly higher strengths are possible as will be apparent from the following examples, The preparation of high molecular weight oriented filaments of poly-p-dioxanone and other polymers of the present invention is further illustrated by the following examples where all percentages are by weight unless otherwise noted, EXAMPLE I
A. Preparation of p-dioxanone Metallic sodium is dissolved in a large excess of ethylene glycol to obtain a glycolate which is further reacted with about 0,5 mols of chloroacetic acid per mole of sodium to yield the sodium salt of the hydroxy acid, Excess ethylene glycol and by-products of the reaction are removed by ^ - 6 -~124~43 distillation and by washing with acetone. The sodium salt is converted to the free hydroxy acid by the addition of hydro-chloric acid, and the resulting sodium chloride is removed by precipitation with ethanol followed by filtration.
m e hydroxy acid filtrate is slowly heated up to about 200C, preferably in the presence of MgC03, to remove alcohol and water by distillation. Upon further heating at atmospheric pressure the p-dioxanone is formed and distills over at a head temperature of between about 200-220C, The purity of the crude dioxanone product is generally about 60-70 percent as determined by gas chromatography and yields are in the order of 50 to 70 percent.
The crude p-dioxanone is further purified to about 98 percent by redistillation, and finally purified to 99+%
by multiple crystallizations and/or distillation.
B, Polymerization of P-dioxanone Highly purified p-dioxanone is polymerized in the presence of an organometallic catalyst such as diethyl zinc or zirconium acetylacetonate to obtain high molecular weight, fiber forming polymers according to the following typical procedure.
0.1 M (10.2 g) of dry, 99+% pure p-dioxanone monomer is weighed into a dry flask under an inert atmosphere of dry nitrogen and 0.36 ml of 0.138M diethyl ZillC in heptane are added, The monomer to catalyst ratio is calculated as 2000:1, After completely mixing the catalyst and monomer, the flask is swirled at intervals over a period of about one hour or less at room temperature until initiation and poly-merization is evident by the occurrence of gelation. The flask is then connected to a vacuum of about 14 inches of Hg.
The sealed flask is maintained at 80C in a constant temper-ature bath for about 72 hours to complete the polymerization, llZ~943 The resulting polymer is characterized by an inherent vis-cosity I.V, of 0,70 measured on a 0.1% solution of polymer in tetrachloroethane at 25C, a glass transition temperature Tg of -16C, a melting temperature Tm of 110C, and a crystallinity of 37 percent.
In the polymerization procedure, the initial one hour hold time for polymerization initiation is required only when using volatile catalysts which would be lost if the polymerization mixture was immediately placed under vacuum.
When non-volatile catalysts such as zirconium acetyl acetonate are used, this hold time may be omitted and the polymerization reaction mixture placed under vacuum immediately following addition and mixing of catalyst. As a further alternative, the entire polymerizat on reaction may be conducted under an inert atmosphere at atmospheric pressure, C. Polymer Extrusion The polymer obtained in the preceding step is thoroughly dried and melt extruded through a spinnerette using conventional textile fiber spinning procedures to obtain one or more continuous monofilament fibers suitable for use as synthetic absorbable sutures, The spun filaments are drawn about 5x at a temperature of about 43C to increase molecular orientation and enhance physical properties, particularly tensile strength. The drawn monofilaments having a diameter of about 11 mils corresponding to a size 2-0 suture are characterized by an inherent viscosity of 0.64, a crystal-linity of 30 percent, a straight tensile strength of 36,600 psi, an elongation of 99.4 percent, and a knot strength of 31,900 psi.
11;24~43 EXAMPLE II
The method of Example I was repeated using 0.13 ml of zirconium acetyl acetonate catalyst (7500 : 1 monomer to catalyst ratio) in the polymerization reaction, Properties of polymer and fiber were as follows:
Polymer: I.V. 0.71 Tm 111C
Crystallinity 49%
Fiber: I.V. 0.57 Tensile Strength 38,600 psi Elongation 88.5 percent Knot Strength 32,300 psi EXAMPLE III
Polydioxanone polymers were prepared in accordance with the polymerization method of Example I using 0,20 ml of zirconium acetyl acetonate catalyst (5000 : 1 monomer to catalyst ratio) and a polymerization temperature of 90C.
Polymer properties were as follows:
I.V. 0.65 Tm 109C
Crystallinity 35~O
EXAMPLE IV
The method of Example III was repeated using 0.50 ml of zirconium acetylacetonate catalyst. (2000 : 1 monomer to catalyst ratio). Polymer properties were as follows:
I,V. 0.59 Tm 111C
Crystallinity 44%
EXAMPLE V
The method of Example I was repeated at a monomer to catalyst ratio of 4000 : 1 and with a polymerization reaction of three days at 80C. The resulting polymer had an inherent viscosity of 0.86 and crystallinity of 30 percent. Fibers _ g _ llZ4943 extruded from the polymer and drawn 6x at 87C had a diameter of 9 mils, a straight tensile strength of 65,100 psi, elon-gation of 47.6%, and knot strength of 46,4000 psi.
EXAMPLE VI
me method of Example I was repeated using tetra-octylene glycol titanate as the polymerization catalyst. The monomer to catalyst ratio was 12,300 : 1 based on titanium content, and the polymerization reaction was maintained at 80C for six days. The resulting polymer had an inherent viscosity of 0.86 and a crystallinity of 33 percent. Extruded filaments drawn 6x at 83C had a diameter of 11 mils, a tensile strength of 55,600 psi, a dry knot strength of 48,800 psi, and a Young's modulus of 167,000 psi.
EXAMPLE VII
Two lots of polydioxanone were prepared according to the method of Example VI using a monomer to catalyst ratio of 26,700 : 1 and with a polymerization reaction of six days ànd 12 days. The resulting polymers had inherent viscosities of 0.81 and 0.84 respectively. The polymers were combined and extruded into fiber which, after drawing 6x, had the following physical properties:
Fiber Diameter 9 mils Tensile Strength 70,600 psi Elongation 46.3 Dry Knot Strength 50,300 psi The monofilament fibers had a high degree of softness and pliability.
EXAMPLE VIII
In Vivo Absorption Two 2 cm segments of monofilament fiber from Example I having a diameter corresponding to size 2-0 suture were implanted aseptically into the left gluteal muscles of 24 11~249~3 female Long Evans rats, The implant sites were recovered after periods of 60, 90, 120 and 180 days and examined micro-scopically to determine the extent of absorption.
After 60 days the suture cross sections were still transparent and intact. The tissue reactions were slight and most sutures were encapsulated with fibrous tissue. The sutures at this period remained birefringent under polarized light.
At 90 days the sutures were becoming translucent and had lost some of their birefringent properties, A few of the suture cross sections stained pink (eosinophilic) around the periphery and the edges were indistinct, indicating the onset of absorption. The tissue reactions generally consisted of a fibrous capsule and a layer of macrophages interposed between it and the suture surface.
At 120 days the sutures were translucent, most cross sections had taken on an eosinophilic stain, and the sutures appeared to be in the process of active absorption, The tissue reactions consisted of an outer layer of fibroblasts with an interface of macrophages several cell layers thick.
Absorption at 120 days was estimated to be approximately 70 percent complete.
At 180 days, absorption of the suture was substan-tially complete. The incision heated with minimal adverse tissue reaction.
EXAMPLE IX
In Vivo Strenqth Retention Segments of the sutures of several Examples were implanted in the posterior dorsal subcutis of female Long Evans rats for periods of 14, 21 and 28 days. The sutures were recovered at the designated periods and tested for ~., 11249~;~
straight tensile strength with the following results.
Implantation Tensile Strength Time Strength Retention Test Fiber Days Pounds %
a) EX, I - 0 3.37 14 1.46 43.4 21 1.14 33.8 28 -___ ____ b) EX. I - (Sterilized)l0 3.08 14 1.16 37.6 21 0.97 31.4 28 0.70 22.9 c) EX. VI - (Unannealed)0 3.47 14 2.27 65.3 21 1.62 46.7 28 1.53 44.1 d) EX. VI - (Annealed)2 0 6.47 14 5.39 83.3 21 4.87 75.3 28 4.30 66.5 e) EX. VI - (Annealed) '0 3.82 14 2.07 54.0 21 1.36 35.5 28 0.68 17.8 f) EX. V - (Sterilized) 0 4.05 14 2.77 68.4 21 2.40 59.3 28 2.15 53.2 g) EX. V - (Sterilized)30 3.45 14 2.11 61.3 21 1.36 39.3 28 0.92 26.6 Sterilized with ethylene oxide at 30C.
Annealed under nitrogen 24 hours at 65C.
Sterilized with cobalt 60.
EXAMPLE X
Small quantitites of polydioxanone polymer were prepared in accordance with the general method of Example I
using chromatographically pure p-dioxanone monomer and diethyl zinc and tetraoctylene glycol titanate as ctalysts. Polymer ,.,,~,.
llZ4943 prepared with diethyl zinc catalyst at a monomer to catalyst ratio of-4,000 and with a polymerization reaction of three days at 80C had an inherent viscosity of 1,18, Polymer pre-pared with tetraoctylene glycol titanate catalyst at a monomer to catalyst ratio of 12,250 and with a polymerization reaction of 6 days at 80C had an inherent viscosity of 1,15, A second batch of high purity p-dioxanone monomer twice distilled in an annular still under a vacuum of 0.10-0,15 mm Hg was polymerized in the presence of tetraoctylene glycol titanate catalyst at a monomer to catalyst ratio of 13,300 and at 80C for 6 days.
The resulting polymer had an inherent viscosity of 2,26.
EXAMPLE XI
Preparation of Methyl-p-Dioxanone Following the general procedure of Example I, metallic sodium was dissolved in a large excess of 1,2~propane diol and chloroacetic acid was added at 110-115C, Excess diol was removed by distillation and the sodium salt of the hydroxy acid converted to free acid by the addition of water and hydrochloric acid, Sodium chloride was precipitated by the addition of ethanol and removed by filtration, The result-ing product was distilled in the presence of MgC03 to remove excess alcohol and water and to recover crude methyl dioxanone monomer as a distillate at 196 to 202C, After purification, the monomer can be polymerized and extruded to form fibers suitable for use as absorbable sutures as described in Example I, EXAMPLE XII
Preparation of DimethYl-p-Dioxanone The procedure of Example XI was repeated reacting metallic sodium with 2,3-butanediol and choroacetic acid at about 130C, Crude dimethyl dioxanone monomer was recovered , , l~Z49~13 from the distillation at 190 to 213C, After purification the monomer can be polymerized and extruded to form fibers suitable for use as absorbable sutures as described in Example I, EXAMPLE XIII
Pre~aration of 1,4-dioxepan-2-one The procedure of Example VI was repeated reacting metallic sodium with 1,3-propane diol and chloroacetic acid.
Crude 1,4-dioxepan-2-one monomer was recovered from the dis-tillation at 300 to 310C. After purification, the monomer can be polymerized and extruded to form fibers suitable for use as absorbable sutures as described in Example I.
****
We have discovered that exceptionally high purity of p-dioxanone monomer is required to obtain polymers having a sufficiently high inherent viscosity to yield strong fibers upon extrusion. In general, the monomers are purified to 99+% by distillation and recrystallization prior to polymer-ization, and the resulting polymers have an inherent viscosity of at least about 0,50, and preferably 0.80 or higher measured as above described. As illustrated in Example X, polymers prepared from highly purified dioxanone have inherent viscosities well in excess of 1.10, Drawn fibers of polydioxanone possess a unique combination of desirable properties, In particular, the mono-filament fibers combine high tensile strength and knot strength with a pliability not to be found in any previous absorbable suture material, natural or synthetic. For example, the Young's modulus of the polydioxanone fiber of Example VI
was 167,200 psi. In comparison, the Young's modulus for monofilament polyglycolide fibers and for 90/10 glycolide/
lactide copolymer fibers is about 1 - 2 million, while that for moist catgut is about 350,000. The low Young's modulus ,,, ~ , , 11;2~943 of polydioxanone makes this fiber particularly well suited for use as an absorbable monofilament suture, whereas prior synthetic absorbable sutures have largely been limited to braided, multifilament constructions which tend to be softer and more flexible than corresponding sizes of monofilament material. Monofilamented sutures are, of course, preferred for use in many surgical applications such as in ophthalmic procedures where smoothness of the suture surface is of particular importance.
The polymers of p-dioxanone of the present invention are also unique as compared with prior synthetic absorbable materials in that the sutures of these polymers can be steri-lized by cobalt 60 radiation as well as by ethylene oxide.
As illustrated in Example IX, while cobalt 60 sterilization results in some reduction in fiber strength and some increase in the in vivo rate of strength loss, the sterilized fiber nevertheless retains sufficient strength initially and for 28 days in vivo to make the fiber suitable for use in surgical procedures.
While the preceding examples have been directed to the preparation of homopolymers of p-dioxanone, methyl dioxanone, dimethyl dioxanone, and 1,4-dioxepan-2-one, these examples are for purposes of illustration only and are not limiting of the invention. Mixtures of these polymers, copolymers of two or more of the above enumerated monomers, and copolymers of these monomers with up to about 50% by weight of other copolymerizable monomers which produce non-toxic and absorbable polymers are likewise included within the present invention For example, such copolymers of dioxanone with lactide and/or glycolide are useful in the preparation of absorbable sutures, and the physical and chemical properties of such sutures such as strength, stiffness, f llZ4943 and rate of absorption can be controlled by varying the relative proportions of the monomer constituents. In addi-tion, the copolymers may be prepared by random, block-or graft polymerization techniques in order to obtain particular com-binations of compositions and physical and chemical properties, In certain applications where the rate of absorption of poly-dioxanone is less than desired, copolymers of dioxanone with from about 5 to 25 percent or more glycolide having a faster rate of absorption may be preferred, It is to be understood that inert additives such as coloring materials and plasticizers can be incorporated in the sutures. Any of a variety of plasticizers such as, for instance, glyceryl triacetate, ethyl benzoate, diethyl phthalate, dibutyl phthalate and bis 2-methoxyethyl phthalate can be used if desired. The amount of plasticizer may vary from 1 to about 20 percent or more based on the weight of the polymer. ~ot only does the plasticizer render the filaments even more pliable, but it also helps in spinning. As used herein, the term "inert" means materials that are chemically inert to the polymer, and biologically inert to living tissue, i.e., do not cause any of the adverse effects previously discussed.
- Filaments of the present invention are adversely affected by moisture and are accordingly preferably packaged in a substantially moisture free environment and in hermetic-ally sealed packages, a preferred form of which is shown in Figure 2. In Figure 2, there is shown a suture package 14 having disposed therein a coil of suture 12, one end of which is attached to needle 13. The needle and suture are positioned within a cavity 16 that is evacuated or filled with a dry atmosphere such as air or nitrogen. The package is fabricated of two sheets of aluminum foil or an aluminum llZ4943 foil-plastic laminate and heat sealed or bonded with adhesive at the skirt 16 to hermetically seal the cavity and isolate the contents of the package from the external atmosphere, Filaments of the present invention may be used as monofilament or multifilament sutures, or may be woven, braided, or knitted either alone or in combination with absorbable fibers such as polyglycolide or poly (lactide-co-glycolide), or with non-absorbable fibers such as nylon, polypropylene, polyethyleneterephthalate, or polytetrafluoro-ethylene to form multifilament sutures and tubular structureshaving use in the surgical repair of arteries, veins, ducts, esophagi and the like, Multifilament yarns that contain polymer filaments of the present invention together with nonabsorbable filaments are illustrated in Figure 4 wherein the nonabsorbable fiber is represented by the hatched fiber cross section 19. In Figure 4, the fibers 20 are extruded from homopolymer or copolymer compositions of the present invention as described above, The relative proportions of absorbable filaments 20 and nonabsorbable filaments 19 may be varied to obtain the absorption characteristic desired in the woven fabric or tubular implants, Methods of weaving and crimping vascular prostheses are described in USP No. 3,096,560, Composite fabrics of absorbable and nonabsorbable materials fashioned by textile processes including weaving, knitting, and fabricating by the nonwoven felting of fibers are described in USP No. 3,108,357 and USP No. 3,463,158.
Similar techniques may be used in the manufacture of surgical aids wherein nonabsorbable fibers are combined with absorbable fibers composed of the polymers of this invention. The surgical utility of "bicomponent filaments" containing absorbable and nonabsorbable components is described in ~,~;s USP No. 3,463,158, Monofilaments of the polymers of the present invention may be woven or knitted to form an absorb-able fabric having the structure illustrated in Figure 5, useful surgically in hernia repair and in supporting damaged liver, kidney, and other internal organs.
The products of the invention are useful in surgical applications where an absorbable aid or support is required, as for example, in the formation of surgical mesh, absorbable staples, artificial tendons, or cartilage material, and in other uses where a temporary aid during healing is needed, They may also be used to advantage in repairing hernias and in anchoring organs which have become loose.
The polymers of the present invention are also use-ful in the manufacture of cast films and other solid surgical aids such as scleral buckling prostheses, Thus, cylindrical pins, screws as illustrated in Figure 3, reinforcing plates, etc., may be machined from the cast polymer having in vivo absorption characteristics depending upon the polymer compo-sition and molecular weight, Many different embodiments of this invention will be apparent to those skilled in the art and may be made without departing from the spirit and scope thereof. It is accordingly understood that this invention is not limited to the specific embodiments thereof except as defined in the appended claims.
,~;P - 18 -
Absorbable suture materials have traditionally been natural collagenous materials obtained from sheep or beef intestine, commonly known as catgut. More recently, it has been proposed to manufacture synthetic absorbable sutures from polyesters of hydroxycarboxylic acids, notably polylactide, polyglycolide, and copolymers of lactide and glycolide, Such synthetic absorbable sutures are described in USP 3,636,956, 3,297,033 and elsewhere in the literature, Among the requirements of an ideal absorbable suture are that it should have good handling properties, should approximate and hold tissue for proper healing with minimal tearing and tissue damage, should have adequate straight tensile and knot strength, should be controllably uniform in properties including dimensional stability within the body, should be sterilizable, should be absorbable by living tissue, preferably at a constant rate regardless of the place in the body or the condition of the patient, with-out causing such unfavorable tissue reactions as walling off, granuloma formation, excessive edema, etc., and finally should be capable of being properly and easily tied into surgical knots.
~ nile multifilament sutures manufactured from polymers of lactide and glycolide fulfill the above require-ments to a large degree, monofilament sutures of these materials are considerably less flexible than catgut and these synthetic sutures are accordingly generally limited llZ4943 to a multifilament, braided construction. Sutures of glycolide polymers are also not suitable for sterilization by radiation without suffering severe degradation of physical properties.
The present invention provides synthetic absorbable sutures having a high degree of softness and flexibility which allows the sutures to be used in monofilament form. The sutures can also be sterilized with cobalt 60 radiation with-out serious loss of suture strength. It is accordingly an object of the present invention to provide synthetic absorb-able sutures having unique and desirable properties not available with the sutures of the prior art.
We have discovered that polymers of p-dioxanone and 1,4-dioxepan-2-one prepared from monomers of very high purity can be melt extruded into pliable, monofilament fibers which are slowly absorbed in animal tissue without significant ad-verse tissue reaction. The fibers have good tensile and knot strength and good in vivo strength retention, and can be sterilized with cobalt 60 without serious loss of these properties.
Polymers of p-dioxanone and fibers extruded there-from have been known in the art. USP 3,063,967 and '968 for example, describe the polymerization of p-dioxanone and the preparation of films and fibers therefrom. The low tensile strength of fibers prepared in accordance with the teachings of these references, however, make these fibers generally unsuitable for use as surgical sutures. Moreover, there was no appreciation in these references of the absorbability of such fibers which were reported to be resistant to the effects of saline and distilled water.
llZ4943~
Other references dealing with the polymerization of p-dioxanone include, but are not limited to, USP 3,190,858, 3,391,126 and 3,645,941 which disclose various catalysts for the polymerization of lactones such as p-dioxanone, and USP
3,020,289 which describes the polymerization of p-dioxanone in the presence of sulfuric acid. None of these references suggest polymers of p-dioxanone or l,4-dioxepan-2-one for use in the preparation of synthetic absorbable sutures in accor-dance with the present invention.
In one aspect of the present invention there is provided a sterile, synthetic absorbable suture comprising oriented fiber of a polymer of a monomer having the formula:
R--ICH ~1--O
~ O ~
wherein R' and R are individually hydrogen, methyl or ethyl, said suture being dry to the extent of being substantially free of moisture, and characterized by a Young's modulus of less than about 600,000 psi with a correspondingly high degree of softness and flexibility, an initial straight tensile and knot strength of at least about 40,000 psi and 30,000 psi respectively, and substantially complete absorption in vivo within about 180 days.
In a further aspect of the present invention there is provided a sterile synthetic absorbable suture comprising oriented fiber of a polymer having units of the formula:
~lZ4~3 ~ 0 R' R Rl l t C- CH- 0--C- CH- 0-~ -R x wherein R' and R are individually hydrogen, methyl, or ethyl and x is the degree of polymerization resulting in a fiber forming polymer, said suture being dry to the extent of being substantially free of moisture, and characterized by a Young's modulus of less than about 600,000 psi with a correspondingly high degree of softness and flexibility, an initial straight tensile and knot strength of at least about 40,000 psi and 30,000 psi respectively, and substantially complete absorption in vivo within about 180 days.
In a further aspect of the present invention there is provided a surgical prosthesis comprising a fabric manufactured at least in part from synthetic absorbable fibers of a polymer having units of the formula:
R~ IR R
C -CH- 0- f_ CH- 0 R x wherein R' and R are individually hydrogen, methyl, or ethyl and x is the degree of polymerization resulting in a fiber forming polymer, said fibers being dry to the extent of being substantially free of moisture, and characterized by a Young's modulus of less than about 600,000 psi with a correspondingly high degree of softness and flexibility, an initial straight tensile and knot strength o~ at least about 40,000 psi and -3a-~49~3 30,000 psi respectively, and substantially complete absorption in vivo within about 180 days.
In a further aspect of the present invention there is provided a surgical prosthesis comprising a solid surgical aid formed from an absorbable polymer having units of the formula:
R' R R
C- CH- 0- f CH- 0 R x wherein R' and R are individually hydrogen, methyl, or ethyl and x is the degree of polymerization resulting in a fiber forming polymer, said prosthesis being dry to the extent of being substantially free of moisture.
In a further aspect of the present invention there is provided a method of closing a wound in living tissue which comprises approximating the edges of the wound with a synthetic absorbable suture consisting of at lea.,t one filament of a polymer of a monomer having the formula:
~0~
R-fH 1=
~ O ~
wherein R' and R are individually hydrogen, methyl or ethyl, said suture being at least partially embedded in the living tissue, and leaving said suture in said tissue until the em-bedded suture is absorbed during the healing process, said suture being characterized by a Young's modulus of less than about 600,000 psi with a correspondingly high degree of softness -3b-~,~
.i. ~, ll~g~4~
and flexibility, an initial straight tensile and knot strength of at least about 40,000 psi and 30,000 psi respectively, and substantially complete absorption in ~ivo within about 180 days.
In a further aspect of the present invention there is provided a method of closing a wound in living tissue which comprises approximating the edge of the wound with a synthetic absorbable suture consisting of at least one filament of a polymer having units of the formula:
O R' R R
_ -C- CH- O- C -CH- O- _ . R x wherein R' and R are individually hydrogen, methyl or ethyl, and x is the degree of polymerization resulting in a fiber forming polymer, said suture being at least partially embedded in the living tissue, and leaving said suture in said tissue until the embedded suture is absorbed during the healing process, said suture being characterized by a Young's modulus of less than about 600,000 psi with a correspondingly high degree of softness and flexibility, an initial straight tensile and knot strength of at least about 40,000 psi and 30,000 psi respectively, and substantially complete absorption in vivo within about 180 days.
DESCRIPTION OF DRAWINGS
FIGURE 1 is a perspective view of a needle-suture combination, FIGURE 2 is a perspective view o a suture-needle combination within a hermetically sealed container' FIGURE 3 illustrates a screw machined from the polymer of the present invention;
FIGURE 4 is a cross-sectional view of a composite yarn containing filaments of different composition and, FIGURE 5 is a plan view of a surgical fabric knitted from fibers of the present invention.
Polymers of the present invention are comprised of units having the general formula:
O R' fi R
_ - C - CH- t C ~ CH - - X
wherein R' and R are individually hydrogen, methyl, or ethyl, n is 1 or 2 provided that when n is 2 at least two R groups are hydrogen, and x is the degree of polymerization resulting in a fiber forming polymer.
The polymer is conveniently prepared from highly purified monomer, i.e., monomer of at least about 98 percent purity, having the formula:
R-CH \ C=O
(R-C-R)n HC-R' \0/
wherein R, R' and n are as defined above. When n is 1, the monomer is preferably p-dioxanone, methyl-p-dioxanone, or di-methyl-p-dioxanone. When n is 2, the monomer is prefer-ably 1,4-dioxepan-2-one.
A particularly preferred monomer is p-dioxanone, and the following description and examples which are presented by way of illustration are directed primarily to the ~lZ4943 .
preparation and polymerization of that monomer, it being understood that certain variations may apply to other monomers and polymers encompassed by the above formula as will be readily apparent to those skilled in the art. Para-dioxanone monomer is conveniently prepared by reacting ethylene glycol, metallic sodium, and chloroacetic acid as hereinafter des-cribed in detail. m e resulting monomer is preferably purified to 99+% purity by multiple distillations and re-crystallizations, We have discovered that high monomer purity is necessary to obtain a high molecular weight polymer and ultimately, a fiber of good tensile and dry knot strength.
The purified monomer is polymerized at a tempera-ture of 20 to 130C, most preferably above 75C, in the presence of an organometallic catalyst as hereinafter des-cribed in detail to obtain a high molecular weight polymer of p-dioxanone characterized by an inherent viscosity of at least about 0.50 measured as a 0.1% solution in tetra-chloroethane at 25C, and a crystallinity of at least about 20% as determined by X-ray diffraction.
me polymer is melt extruded through a spinneret in a conventional manner to form one or more filaments which are subsequently drawn about 4x to 6x in order to achieve molecular orientation and improve tensile properties. The resulting oriented filaments have good tensile and dry knot strength and good in vivo strength retention.
To further improve dimensional stability and tensile strength retention, the oriented filaments may be subjected to an annealing treatment. This optional annealing treatment consists of heating the filaments to a temperature of from about 50 to 105C, most preferably from about 50 to 80C
while restraining the filaments to prevent any substantial '~' llZ4943 shrinkage, The filaments are held at the annealing temper-ature for a few seconds to several days or longer depending on the temperature and processing conditions, In general, annealing at 50 to 80C for up to about 24 hours is satis-factory for p-dioxanone, Optimum annealing time and temper-ature for maximum improvement in fiber in vivo strength retention and dimensional stability is readily determined for each fiber composition, Since the function of a suture is to join and hold severed tissue until healing is well along, and to prevent separation as a result of movement or exercise, a suture must meet certain minimum standards of strength, It is particularly important that strength be maintained when knots are tied and during the actual procedure of drawing tight a suitable knot, Oriented filaments of the present invention are characterized by a straight tensile strength of at least about 40,000 psi and a knot strength of at least about 30,000 psi, although significantly higher strengths are possible as will be apparent from the following examples, The preparation of high molecular weight oriented filaments of poly-p-dioxanone and other polymers of the present invention is further illustrated by the following examples where all percentages are by weight unless otherwise noted, EXAMPLE I
A. Preparation of p-dioxanone Metallic sodium is dissolved in a large excess of ethylene glycol to obtain a glycolate which is further reacted with about 0,5 mols of chloroacetic acid per mole of sodium to yield the sodium salt of the hydroxy acid, Excess ethylene glycol and by-products of the reaction are removed by ^ - 6 -~124~43 distillation and by washing with acetone. The sodium salt is converted to the free hydroxy acid by the addition of hydro-chloric acid, and the resulting sodium chloride is removed by precipitation with ethanol followed by filtration.
m e hydroxy acid filtrate is slowly heated up to about 200C, preferably in the presence of MgC03, to remove alcohol and water by distillation. Upon further heating at atmospheric pressure the p-dioxanone is formed and distills over at a head temperature of between about 200-220C, The purity of the crude dioxanone product is generally about 60-70 percent as determined by gas chromatography and yields are in the order of 50 to 70 percent.
The crude p-dioxanone is further purified to about 98 percent by redistillation, and finally purified to 99+%
by multiple crystallizations and/or distillation.
B, Polymerization of P-dioxanone Highly purified p-dioxanone is polymerized in the presence of an organometallic catalyst such as diethyl zinc or zirconium acetylacetonate to obtain high molecular weight, fiber forming polymers according to the following typical procedure.
0.1 M (10.2 g) of dry, 99+% pure p-dioxanone monomer is weighed into a dry flask under an inert atmosphere of dry nitrogen and 0.36 ml of 0.138M diethyl ZillC in heptane are added, The monomer to catalyst ratio is calculated as 2000:1, After completely mixing the catalyst and monomer, the flask is swirled at intervals over a period of about one hour or less at room temperature until initiation and poly-merization is evident by the occurrence of gelation. The flask is then connected to a vacuum of about 14 inches of Hg.
The sealed flask is maintained at 80C in a constant temper-ature bath for about 72 hours to complete the polymerization, llZ~943 The resulting polymer is characterized by an inherent vis-cosity I.V, of 0,70 measured on a 0.1% solution of polymer in tetrachloroethane at 25C, a glass transition temperature Tg of -16C, a melting temperature Tm of 110C, and a crystallinity of 37 percent.
In the polymerization procedure, the initial one hour hold time for polymerization initiation is required only when using volatile catalysts which would be lost if the polymerization mixture was immediately placed under vacuum.
When non-volatile catalysts such as zirconium acetyl acetonate are used, this hold time may be omitted and the polymerization reaction mixture placed under vacuum immediately following addition and mixing of catalyst. As a further alternative, the entire polymerizat on reaction may be conducted under an inert atmosphere at atmospheric pressure, C. Polymer Extrusion The polymer obtained in the preceding step is thoroughly dried and melt extruded through a spinnerette using conventional textile fiber spinning procedures to obtain one or more continuous monofilament fibers suitable for use as synthetic absorbable sutures, The spun filaments are drawn about 5x at a temperature of about 43C to increase molecular orientation and enhance physical properties, particularly tensile strength. The drawn monofilaments having a diameter of about 11 mils corresponding to a size 2-0 suture are characterized by an inherent viscosity of 0.64, a crystal-linity of 30 percent, a straight tensile strength of 36,600 psi, an elongation of 99.4 percent, and a knot strength of 31,900 psi.
11;24~43 EXAMPLE II
The method of Example I was repeated using 0.13 ml of zirconium acetyl acetonate catalyst (7500 : 1 monomer to catalyst ratio) in the polymerization reaction, Properties of polymer and fiber were as follows:
Polymer: I.V. 0.71 Tm 111C
Crystallinity 49%
Fiber: I.V. 0.57 Tensile Strength 38,600 psi Elongation 88.5 percent Knot Strength 32,300 psi EXAMPLE III
Polydioxanone polymers were prepared in accordance with the polymerization method of Example I using 0,20 ml of zirconium acetyl acetonate catalyst (5000 : 1 monomer to catalyst ratio) and a polymerization temperature of 90C.
Polymer properties were as follows:
I.V. 0.65 Tm 109C
Crystallinity 35~O
EXAMPLE IV
The method of Example III was repeated using 0.50 ml of zirconium acetylacetonate catalyst. (2000 : 1 monomer to catalyst ratio). Polymer properties were as follows:
I,V. 0.59 Tm 111C
Crystallinity 44%
EXAMPLE V
The method of Example I was repeated at a monomer to catalyst ratio of 4000 : 1 and with a polymerization reaction of three days at 80C. The resulting polymer had an inherent viscosity of 0.86 and crystallinity of 30 percent. Fibers _ g _ llZ4943 extruded from the polymer and drawn 6x at 87C had a diameter of 9 mils, a straight tensile strength of 65,100 psi, elon-gation of 47.6%, and knot strength of 46,4000 psi.
EXAMPLE VI
me method of Example I was repeated using tetra-octylene glycol titanate as the polymerization catalyst. The monomer to catalyst ratio was 12,300 : 1 based on titanium content, and the polymerization reaction was maintained at 80C for six days. The resulting polymer had an inherent viscosity of 0.86 and a crystallinity of 33 percent. Extruded filaments drawn 6x at 83C had a diameter of 11 mils, a tensile strength of 55,600 psi, a dry knot strength of 48,800 psi, and a Young's modulus of 167,000 psi.
EXAMPLE VII
Two lots of polydioxanone were prepared according to the method of Example VI using a monomer to catalyst ratio of 26,700 : 1 and with a polymerization reaction of six days ànd 12 days. The resulting polymers had inherent viscosities of 0.81 and 0.84 respectively. The polymers were combined and extruded into fiber which, after drawing 6x, had the following physical properties:
Fiber Diameter 9 mils Tensile Strength 70,600 psi Elongation 46.3 Dry Knot Strength 50,300 psi The monofilament fibers had a high degree of softness and pliability.
EXAMPLE VIII
In Vivo Absorption Two 2 cm segments of monofilament fiber from Example I having a diameter corresponding to size 2-0 suture were implanted aseptically into the left gluteal muscles of 24 11~249~3 female Long Evans rats, The implant sites were recovered after periods of 60, 90, 120 and 180 days and examined micro-scopically to determine the extent of absorption.
After 60 days the suture cross sections were still transparent and intact. The tissue reactions were slight and most sutures were encapsulated with fibrous tissue. The sutures at this period remained birefringent under polarized light.
At 90 days the sutures were becoming translucent and had lost some of their birefringent properties, A few of the suture cross sections stained pink (eosinophilic) around the periphery and the edges were indistinct, indicating the onset of absorption. The tissue reactions generally consisted of a fibrous capsule and a layer of macrophages interposed between it and the suture surface.
At 120 days the sutures were translucent, most cross sections had taken on an eosinophilic stain, and the sutures appeared to be in the process of active absorption, The tissue reactions consisted of an outer layer of fibroblasts with an interface of macrophages several cell layers thick.
Absorption at 120 days was estimated to be approximately 70 percent complete.
At 180 days, absorption of the suture was substan-tially complete. The incision heated with minimal adverse tissue reaction.
EXAMPLE IX
In Vivo Strenqth Retention Segments of the sutures of several Examples were implanted in the posterior dorsal subcutis of female Long Evans rats for periods of 14, 21 and 28 days. The sutures were recovered at the designated periods and tested for ~., 11249~;~
straight tensile strength with the following results.
Implantation Tensile Strength Time Strength Retention Test Fiber Days Pounds %
a) EX, I - 0 3.37 14 1.46 43.4 21 1.14 33.8 28 -___ ____ b) EX. I - (Sterilized)l0 3.08 14 1.16 37.6 21 0.97 31.4 28 0.70 22.9 c) EX. VI - (Unannealed)0 3.47 14 2.27 65.3 21 1.62 46.7 28 1.53 44.1 d) EX. VI - (Annealed)2 0 6.47 14 5.39 83.3 21 4.87 75.3 28 4.30 66.5 e) EX. VI - (Annealed) '0 3.82 14 2.07 54.0 21 1.36 35.5 28 0.68 17.8 f) EX. V - (Sterilized) 0 4.05 14 2.77 68.4 21 2.40 59.3 28 2.15 53.2 g) EX. V - (Sterilized)30 3.45 14 2.11 61.3 21 1.36 39.3 28 0.92 26.6 Sterilized with ethylene oxide at 30C.
Annealed under nitrogen 24 hours at 65C.
Sterilized with cobalt 60.
EXAMPLE X
Small quantitites of polydioxanone polymer were prepared in accordance with the general method of Example I
using chromatographically pure p-dioxanone monomer and diethyl zinc and tetraoctylene glycol titanate as ctalysts. Polymer ,.,,~,.
llZ4943 prepared with diethyl zinc catalyst at a monomer to catalyst ratio of-4,000 and with a polymerization reaction of three days at 80C had an inherent viscosity of 1,18, Polymer pre-pared with tetraoctylene glycol titanate catalyst at a monomer to catalyst ratio of 12,250 and with a polymerization reaction of 6 days at 80C had an inherent viscosity of 1,15, A second batch of high purity p-dioxanone monomer twice distilled in an annular still under a vacuum of 0.10-0,15 mm Hg was polymerized in the presence of tetraoctylene glycol titanate catalyst at a monomer to catalyst ratio of 13,300 and at 80C for 6 days.
The resulting polymer had an inherent viscosity of 2,26.
EXAMPLE XI
Preparation of Methyl-p-Dioxanone Following the general procedure of Example I, metallic sodium was dissolved in a large excess of 1,2~propane diol and chloroacetic acid was added at 110-115C, Excess diol was removed by distillation and the sodium salt of the hydroxy acid converted to free acid by the addition of water and hydrochloric acid, Sodium chloride was precipitated by the addition of ethanol and removed by filtration, The result-ing product was distilled in the presence of MgC03 to remove excess alcohol and water and to recover crude methyl dioxanone monomer as a distillate at 196 to 202C, After purification, the monomer can be polymerized and extruded to form fibers suitable for use as absorbable sutures as described in Example I, EXAMPLE XII
Preparation of DimethYl-p-Dioxanone The procedure of Example XI was repeated reacting metallic sodium with 2,3-butanediol and choroacetic acid at about 130C, Crude dimethyl dioxanone monomer was recovered , , l~Z49~13 from the distillation at 190 to 213C, After purification the monomer can be polymerized and extruded to form fibers suitable for use as absorbable sutures as described in Example I, EXAMPLE XIII
Pre~aration of 1,4-dioxepan-2-one The procedure of Example VI was repeated reacting metallic sodium with 1,3-propane diol and chloroacetic acid.
Crude 1,4-dioxepan-2-one monomer was recovered from the dis-tillation at 300 to 310C. After purification, the monomer can be polymerized and extruded to form fibers suitable for use as absorbable sutures as described in Example I.
****
We have discovered that exceptionally high purity of p-dioxanone monomer is required to obtain polymers having a sufficiently high inherent viscosity to yield strong fibers upon extrusion. In general, the monomers are purified to 99+% by distillation and recrystallization prior to polymer-ization, and the resulting polymers have an inherent viscosity of at least about 0,50, and preferably 0.80 or higher measured as above described. As illustrated in Example X, polymers prepared from highly purified dioxanone have inherent viscosities well in excess of 1.10, Drawn fibers of polydioxanone possess a unique combination of desirable properties, In particular, the mono-filament fibers combine high tensile strength and knot strength with a pliability not to be found in any previous absorbable suture material, natural or synthetic. For example, the Young's modulus of the polydioxanone fiber of Example VI
was 167,200 psi. In comparison, the Young's modulus for monofilament polyglycolide fibers and for 90/10 glycolide/
lactide copolymer fibers is about 1 - 2 million, while that for moist catgut is about 350,000. The low Young's modulus ,,, ~ , , 11;2~943 of polydioxanone makes this fiber particularly well suited for use as an absorbable monofilament suture, whereas prior synthetic absorbable sutures have largely been limited to braided, multifilament constructions which tend to be softer and more flexible than corresponding sizes of monofilament material. Monofilamented sutures are, of course, preferred for use in many surgical applications such as in ophthalmic procedures where smoothness of the suture surface is of particular importance.
The polymers of p-dioxanone of the present invention are also unique as compared with prior synthetic absorbable materials in that the sutures of these polymers can be steri-lized by cobalt 60 radiation as well as by ethylene oxide.
As illustrated in Example IX, while cobalt 60 sterilization results in some reduction in fiber strength and some increase in the in vivo rate of strength loss, the sterilized fiber nevertheless retains sufficient strength initially and for 28 days in vivo to make the fiber suitable for use in surgical procedures.
While the preceding examples have been directed to the preparation of homopolymers of p-dioxanone, methyl dioxanone, dimethyl dioxanone, and 1,4-dioxepan-2-one, these examples are for purposes of illustration only and are not limiting of the invention. Mixtures of these polymers, copolymers of two or more of the above enumerated monomers, and copolymers of these monomers with up to about 50% by weight of other copolymerizable monomers which produce non-toxic and absorbable polymers are likewise included within the present invention For example, such copolymers of dioxanone with lactide and/or glycolide are useful in the preparation of absorbable sutures, and the physical and chemical properties of such sutures such as strength, stiffness, f llZ4943 and rate of absorption can be controlled by varying the relative proportions of the monomer constituents. In addi-tion, the copolymers may be prepared by random, block-or graft polymerization techniques in order to obtain particular com-binations of compositions and physical and chemical properties, In certain applications where the rate of absorption of poly-dioxanone is less than desired, copolymers of dioxanone with from about 5 to 25 percent or more glycolide having a faster rate of absorption may be preferred, It is to be understood that inert additives such as coloring materials and plasticizers can be incorporated in the sutures. Any of a variety of plasticizers such as, for instance, glyceryl triacetate, ethyl benzoate, diethyl phthalate, dibutyl phthalate and bis 2-methoxyethyl phthalate can be used if desired. The amount of plasticizer may vary from 1 to about 20 percent or more based on the weight of the polymer. ~ot only does the plasticizer render the filaments even more pliable, but it also helps in spinning. As used herein, the term "inert" means materials that are chemically inert to the polymer, and biologically inert to living tissue, i.e., do not cause any of the adverse effects previously discussed.
- Filaments of the present invention are adversely affected by moisture and are accordingly preferably packaged in a substantially moisture free environment and in hermetic-ally sealed packages, a preferred form of which is shown in Figure 2. In Figure 2, there is shown a suture package 14 having disposed therein a coil of suture 12, one end of which is attached to needle 13. The needle and suture are positioned within a cavity 16 that is evacuated or filled with a dry atmosphere such as air or nitrogen. The package is fabricated of two sheets of aluminum foil or an aluminum llZ4943 foil-plastic laminate and heat sealed or bonded with adhesive at the skirt 16 to hermetically seal the cavity and isolate the contents of the package from the external atmosphere, Filaments of the present invention may be used as monofilament or multifilament sutures, or may be woven, braided, or knitted either alone or in combination with absorbable fibers such as polyglycolide or poly (lactide-co-glycolide), or with non-absorbable fibers such as nylon, polypropylene, polyethyleneterephthalate, or polytetrafluoro-ethylene to form multifilament sutures and tubular structureshaving use in the surgical repair of arteries, veins, ducts, esophagi and the like, Multifilament yarns that contain polymer filaments of the present invention together with nonabsorbable filaments are illustrated in Figure 4 wherein the nonabsorbable fiber is represented by the hatched fiber cross section 19. In Figure 4, the fibers 20 are extruded from homopolymer or copolymer compositions of the present invention as described above, The relative proportions of absorbable filaments 20 and nonabsorbable filaments 19 may be varied to obtain the absorption characteristic desired in the woven fabric or tubular implants, Methods of weaving and crimping vascular prostheses are described in USP No. 3,096,560, Composite fabrics of absorbable and nonabsorbable materials fashioned by textile processes including weaving, knitting, and fabricating by the nonwoven felting of fibers are described in USP No. 3,108,357 and USP No. 3,463,158.
Similar techniques may be used in the manufacture of surgical aids wherein nonabsorbable fibers are combined with absorbable fibers composed of the polymers of this invention. The surgical utility of "bicomponent filaments" containing absorbable and nonabsorbable components is described in ~,~;s USP No. 3,463,158, Monofilaments of the polymers of the present invention may be woven or knitted to form an absorb-able fabric having the structure illustrated in Figure 5, useful surgically in hernia repair and in supporting damaged liver, kidney, and other internal organs.
The products of the invention are useful in surgical applications where an absorbable aid or support is required, as for example, in the formation of surgical mesh, absorbable staples, artificial tendons, or cartilage material, and in other uses where a temporary aid during healing is needed, They may also be used to advantage in repairing hernias and in anchoring organs which have become loose.
The polymers of the present invention are also use-ful in the manufacture of cast films and other solid surgical aids such as scleral buckling prostheses, Thus, cylindrical pins, screws as illustrated in Figure 3, reinforcing plates, etc., may be machined from the cast polymer having in vivo absorption characteristics depending upon the polymer compo-sition and molecular weight, Many different embodiments of this invention will be apparent to those skilled in the art and may be made without departing from the spirit and scope thereof. It is accordingly understood that this invention is not limited to the specific embodiments thereof except as defined in the appended claims.
,~;P - 18 -
Claims (26)
1. A sterile, synthetic absorbable suture comprising oriented fiber of a polymer of a monomer having the formula:
wherein R' and R are individually hydrogen, methyl or ethyl, said suture being dry to the extent of being substantially free of moisture, and characterized by a Young's modulus of less than about 600,000 psi with a correspondingly high degree of softness and flexibility, an initial straight tensile and knot strength of at least about 40,000 psi and 30,000 psi res-pectively, and substantially complete absorption in vivo within about 180 days, said polymer having an inherent viscosity greater than about 0.50 measured as 0.1% solution of polymer in tetra-chloroethane at 25°C.
wherein R' and R are individually hydrogen, methyl or ethyl, said suture being dry to the extent of being substantially free of moisture, and characterized by a Young's modulus of less than about 600,000 psi with a correspondingly high degree of softness and flexibility, an initial straight tensile and knot strength of at least about 40,000 psi and 30,000 psi res-pectively, and substantially complete absorption in vivo within about 180 days, said polymer having an inherent viscosity greater than about 0.50 measured as 0.1% solution of polymer in tetra-chloroethane at 25°C.
2. A suture of claim 1 wherein R and R° are hydrogen and the monomer is p-dioxanone.
3. A suture of claim 1 comprising a homopolymer of p-dioxanone.
4. A suture of claim 1 comprising a polymer of methyl-p-dioxanone.
5. A suture of claim 1 comprising a polymer of dimethyl-p-dioxanone.
6. A suture of claim 1 comprising a copolymer of more than 50% by weight p-dioxanone and less than 50% by weight of at least one other monomer copolymerizable with p-dioxanone to an absorbable polymer.
7. A suture of claim 6 wherein said copolymer is of p-dioxanone and glycolide or lactide.
8. A sterile synthetic absorbable suture comprising oriented fiber of a polymer having units of the formula:
wherein R' and R are individually hydrogen, methyl, or ethyl and x is the degree of polymerization resulting in a fiber forming polymer, said suture being dry to the extent of being substan-tially free of moisture, and characterized by a Young's modulus of less than about 600,000 psi with a correspondingly high degree of softness and flexibility, an initial straight tensile and knot strength of at least about 40,000 psi and 30,000 psi respectively, and substantially complete absorption in vivo within about 180 days, said polymer having an inherent viscosity greater than about 0.50 measured as 0.1% solution of polymer in tetrachloroethane at 25°C,
wherein R' and R are individually hydrogen, methyl, or ethyl and x is the degree of polymerization resulting in a fiber forming polymer, said suture being dry to the extent of being substan-tially free of moisture, and characterized by a Young's modulus of less than about 600,000 psi with a correspondingly high degree of softness and flexibility, an initial straight tensile and knot strength of at least about 40,000 psi and 30,000 psi respectively, and substantially complete absorption in vivo within about 180 days, said polymer having an inherent viscosity greater than about 0.50 measured as 0.1% solution of polymer in tetrachloroethane at 25°C,
9. A suture of claim 8 wherein said polymer is a homo-polymer of p-dioxanone having an inherent viscosity of at least 0.50 in a 0.1% solution of tetrachloroethane at 25°C,
10. A suture of claim 9 wherein the inherent viscosity of said polymer is at least 0.80.
11. A suture of claim 8 wherein said polymer is a copoly-mer of more than 50% by weight p-dioxanone with less than 50%
by weight of at least one other monomer copolymerizable to an absorbable polymer.
by weight of at least one other monomer copolymerizable to an absorbable polymer.
12. A suture of claim 11 wherein said polymer is a copolymer of p-dioxanone and lactide or glycolide.
13. A suture of claim 9 wherein said polymer is a homo-polymer of methyl-p-dioxanone or copolymer of more than 50%
by weight methyl-p-dioxanone with less than 50% by weight of at least one other monomer copolymerizable to an absorbable polymer.
by weight methyl-p-dioxanone with less than 50% by weight of at least one other monomer copolymerizable to an absorbable polymer.
14. A suture of claim 8 wherein said polymer is a homo-polymer of dimenthyl-p-dioxanone or copolymer of more than 50%
by weight dimenthyl-p-dioxanone with less than 50% by weight of at least one other monomer copolymerizable to an absorbable polymer.
by weight dimenthyl-p-dioxanone with less than 50% by weight of at least one other monomer copolymerizable to an absorbable polymer.
15. A suture of claim 1 having a surgical needle attached to at least one end thereof.
16. A needle and suture combination of claim 15 packaged in a sterile and dry environment within a hermetically sealed and substantially moisture impervious container.
17. A suture of claim 8 having a surgical needle attached to at least one end thereof.
18. A needle and suture combination of claim 17 packaged in a sterile and dry environment within a hermetically sealed and substantially moisture impervious container.
19. A surgical prosthesis comprising a fabric manufac-tured at least in part from synthetic absorbable fibers of a polymer having units of the formula:
wherein R' and R are individually hydrogen, methyl, or ethyl and x is the degree of polymerization resulting in a fiber forming polymer, said fibers being dry to the extent of being substantially free of moisture, and characterized by a Young's modulus of less than about 600,000 psi with a correspondingly high degree of softness and flexibility, an initial straight tensile and knot strength of at least about 40,000 psi and 30,000 psi respectively, and substantially complete absorption in vivo within about 180 days, said polymer having an inherent viscosity greater than about 0.50 measured as 0.1% solution of polymer in tetrachloroethane at 25°C.
wherein R' and R are individually hydrogen, methyl, or ethyl and x is the degree of polymerization resulting in a fiber forming polymer, said fibers being dry to the extent of being substantially free of moisture, and characterized by a Young's modulus of less than about 600,000 psi with a correspondingly high degree of softness and flexibility, an initial straight tensile and knot strength of at least about 40,000 psi and 30,000 psi respectively, and substantially complete absorption in vivo within about 180 days, said polymer having an inherent viscosity greater than about 0.50 measured as 0.1% solution of polymer in tetrachloroethane at 25°C.
20. A surgical prosthesis of claim 19 wherein said poly-mer is a homopolymer of p-dioxanone or a copolymer of more than 50% by weight p-dioxanone with less than 50% by weight of at least one other monomer copolymerizable to an absorbable polymer.
21. A surgical prosthesis of claim 19 wherein said polymer is a homopolymer of methyl-p-dioxanone or a copolymer of more than 50% by weight methyl-p-dioxanone with less than 50% by weight of at least one other monomer copolymerizable to an absorbable polymer.
22. A surgical prosthesis of claim 19 wherein said polymer is a homopolymer of dimethyl-p-dioxanone or a copolymer of more than 50% by weight dimethyl-p-dioxanone with less than 50% by weight of at least one other monomer copolymerizable to an absorbable polymer.
23. A surgical prosthesis comprising a solid surgical aid formed from an absorbable polymer having units of the formula:
wherein R' and R are individually hydrogen, methyl, or ethyl and x is the degree of polymerization resulting in a fiber forming polymer, said prosthesis being dry to the extent of being substantially free of moisture, wherein said poly-mer is a homopolymer of p-dioxanone having an inherent vis-cosity of at least 0.05 in a 0.1% solution of tetrachloro-ethane at 25°C.
wherein R' and R are individually hydrogen, methyl, or ethyl and x is the degree of polymerization resulting in a fiber forming polymer, said prosthesis being dry to the extent of being substantially free of moisture, wherein said poly-mer is a homopolymer of p-dioxanone having an inherent vis-cosity of at least 0.05 in a 0.1% solution of tetrachloro-ethane at 25°C.
24. A surgical prosthesis of claim 23 wherein said poly-mer is a copolymer of at least 50% by weight p-dioxanone with less than 50% by weight of at least one other monomer copoly-merizable to an absorbable polymer.
25. A surgical prosthesis of claim 23 wherein said poly-mer is a homopolymer of methyl-p-dioxanone or a copolymer of more than 50% by weight methyl-p-dioxanone with less than 50%
by weight of at least one other monomer copolymerizable to an absorbable polymer.
by weight of at least one other monomer copolymerizable to an absorbable polymer.
26. A surgical prosthesis of claim 23 wherein said polymer is a homopolymer of dimethyl-p-dioxanone or a copolymer of more than 50% by weight dimethyl-p-dioxanone with less than 50% by weight of at least one other monomer copolymerizable to an absorbable polymer.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/648,236 US4052988A (en) | 1976-01-12 | 1976-01-12 | Synthetic absorbable surgical devices of poly-dioxanone |
| US648,236 | 1976-01-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1124943A true CA1124943A (en) | 1982-06-01 |
Family
ID=24599973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA269,401A Expired CA1124943A (en) | 1976-01-12 | 1977-01-10 | Synthetic absorbable surgical devices of poly-dioxanone |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4052988A (en) |
| JP (2) | JPS6036785B2 (en) |
| AT (1) | AT352898B (en) |
| AU (1) | AU506167B2 (en) |
| BE (1) | BE850247A (en) |
| BR (1) | BR7700141A (en) |
| CA (1) | CA1124943A (en) |
| CH (2) | CH637835A5 (en) |
| DE (1) | DE2700729C2 (en) |
| FR (2) | FR2357234A1 (en) |
| GB (1) | GB1540053A (en) |
| GR (1) | GR60784B (en) |
| IL (1) | IL51240A (en) |
| IN (1) | IN145409B (en) |
| IT (1) | IT1086656B (en) |
| NL (1) | NL185350C (en) |
| PL (1) | PL195268A1 (en) |
| PT (1) | PT66060B (en) |
| SE (3) | SE445297B (en) |
| TR (1) | TR19478A (en) |
| ZA (1) | ZA77124B (en) |
Families Citing this family (279)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4190720A (en) * | 1978-12-26 | 1980-02-26 | Ethicon, Inc. | Isomorphic copolymers of ε-caprolactone and 1,5-dioxepan-2-one |
| DE2917446A1 (en) * | 1979-04-28 | 1980-11-06 | Merck Patent Gmbh | SURGICAL MATERIAL |
| US4343931A (en) * | 1979-12-17 | 1982-08-10 | Minnesota Mining And Manufacturing Company | Synthetic absorbable surgical devices of poly(esteramides) |
| US4529792A (en) * | 1979-12-17 | 1985-07-16 | Minnesota Mining And Manufacturing Company | Process for preparing synthetic absorbable poly(esteramides) |
| JPS5827548A (en) * | 1981-07-30 | 1983-02-18 | エチコン・インコ−ポレ−テツド | Annealed polydioxane surgical instrument and production thereof |
| US4620541A (en) * | 1981-07-30 | 1986-11-04 | Ethicon, Inc. | Annealed polydioxanone surgical device having a resilient portion and an interlocking portion and method for producing the same |
| US4591630A (en) * | 1981-07-30 | 1986-05-27 | Ethicon, Inc. | Annealed polydioxanone surgical device and method for producing the same |
| US4490326A (en) * | 1981-07-30 | 1984-12-25 | Ethicon, Inc. | Molding process for polydioxanone polymers |
| US4550729A (en) * | 1981-08-27 | 1985-11-05 | Ethicon, Inc. | Non-metallic, bio-compatible hemostatic clips with interlocking latch means |
| US4449531A (en) * | 1981-08-27 | 1984-05-22 | Ethicon, Inc. | Non-metallic, bio-compatible hemostatic clips with interlocking latch means |
| US4441496A (en) * | 1982-02-08 | 1984-04-10 | Ethicon, Inc. | Copolymers of p-dioxanone and 2,5-morpholinediones and surgical devices formed therefrom having accelerated absorption characteristics |
| US4444927A (en) * | 1982-09-13 | 1984-04-24 | Ethicon, Inc. | Sucrose and/or lactose nucleating agents for the crystallization of polydioxanone |
| US4440789A (en) * | 1982-11-16 | 1984-04-03 | Ethicon, Inc. | Synthetic absorbable hemostatic composition |
| EP0134813B1 (en) * | 1983-02-02 | 1989-04-26 | Minnesota Mining And Manufacturing Company | Absorbable nerve repair device and method |
| US4470416A (en) * | 1983-06-17 | 1984-09-11 | Ethicon, Inc. | Copolymers of lactide and/or glycolide with 1,5-dioxepan-2-one |
| JPS6014861A (en) * | 1983-07-05 | 1985-01-25 | 株式会社日本メデイカル・サプライ | Adhesion preventing material |
| US4546152A (en) * | 1984-03-07 | 1985-10-08 | Ethicon, Inc. | Poly(p-dioxanone) polymers having improved radiation resistance |
| US4649921A (en) * | 1984-03-07 | 1987-03-17 | Ethicon, Inc. | Poly(p-dioxanone) polymers having improved radiation resistance |
| US4646741A (en) * | 1984-11-09 | 1987-03-03 | Ethicon, Inc. | Surgical fastener made from polymeric blends |
| EP0185467A3 (en) * | 1984-11-19 | 1987-11-11 | Ethicon, Inc. | Compatible blends of poly(p-dioxanone) and poly(alkylene phenylene-bis-oxyacetate)and absorbable surgical devices made therefrom |
| US4697575A (en) * | 1984-11-21 | 1987-10-06 | Henry Ford Hospital | Delivery system for interstitial radiation therapy including substantially non-deflecting elongated member |
| US4754745A (en) * | 1984-11-21 | 1988-07-05 | Horowitz Bruce S | Conformable sheet material for use in brachytherapy |
| US4604097A (en) * | 1985-02-19 | 1986-08-05 | University Of Dayton | Bioabsorbable glass fibers for use in the reinforcement of bioabsorbable polymers for bone fixation devices and artificial ligaments |
| US4955913A (en) * | 1985-03-28 | 1990-09-11 | Robinson Walter C | Surgical tie |
| FI75493C (en) * | 1985-05-08 | 1988-07-11 | Materials Consultants Oy | SJAELVARMERAT ABSORBERBART PURCHASING SYNTHESIS. |
| US4671280A (en) * | 1985-05-13 | 1987-06-09 | Ethicon, Inc. | Surgical fastening device and method for manufacture |
| FI78238C (en) * | 1985-07-09 | 1989-07-10 | Biocon Oy | SURGICAL PURPOSE SYNTHESIS. |
| US5013315A (en) * | 1985-07-12 | 1991-05-07 | Minnesota Mining And Manufacturing Company | Semiabsorbable bone plate spacer |
| US4889119A (en) * | 1985-07-17 | 1989-12-26 | Ethicon, Inc. | Surgical fastener made from glycolide-rich polymer blends |
| US4653497A (en) * | 1985-11-29 | 1987-03-31 | Ethicon, Inc. | Crystalline p-dioxanone/glycolide copolymers and surgical devices made therefrom |
| US4643191A (en) * | 1985-11-29 | 1987-02-17 | Ethicon, Inc. | Crystalline copolymers of p-dioxanone and lactide and surgical devices made therefrom |
| DE3601715A1 (en) * | 1986-01-22 | 1987-07-23 | Heinl Thomas | SURGICAL INSTRUMENT SET FOR CONNECTING BONE FRAGMENTS |
| US4759765A (en) * | 1986-03-17 | 1988-07-26 | Minnesota Mining And Manufacturing Company | Tissue augmentation device |
| US4763642A (en) * | 1986-04-07 | 1988-08-16 | Horowitz Bruce S | Intracavitational brachytherapy |
| JPS6368155A (en) * | 1986-09-11 | 1988-03-28 | グンゼ株式会社 | Bone bonding pin |
| FI81498C (en) * | 1987-01-13 | 1990-11-12 | Biocon Oy | SURGICAL MATERIAL OCH INSTRUMENT. |
| US5306289A (en) * | 1987-08-26 | 1994-04-26 | United States Surgical Corporation | Braided suture of improved characteristics |
| US5226912A (en) * | 1987-08-26 | 1993-07-13 | United States Surgical Corporation | Combined surgical needle-braided suture device |
| US5037429A (en) * | 1987-08-26 | 1991-08-06 | United States Surgical Corporation | Method for improving the storage stability of a polymeric braided suture susceptible to hydrolytic degradation and resulting article |
| US5366081A (en) * | 1987-08-26 | 1994-11-22 | United States Surgical Corporation | Packaged synthetic absorbable surgical elements |
| US5222978A (en) * | 1987-08-26 | 1993-06-29 | United States Surgical Corporation | Packaged synthetic absorbable surgical elements |
| US5129889A (en) * | 1987-11-03 | 1992-07-14 | Hahn John L | Synthetic absorbable epidural catheter |
| US5145945A (en) * | 1987-12-17 | 1992-09-08 | Allied-Signal Inc. | Homopolymers and copolymers having recurring carbonate units |
| US5256764A (en) * | 1987-12-17 | 1993-10-26 | United States Surgical Corporation | Medical devices fabricated from homopolymers and copolymers having recurring carbonate units |
| US5120802A (en) * | 1987-12-17 | 1992-06-09 | Allied-Signal Inc. | Polycarbonate-based block copolymers and devices |
| US4891263A (en) * | 1987-12-17 | 1990-01-02 | Allied-Signal Inc. | Polycarbonate random copolymer-based fiber compositions and method of melt-spinning same and device |
| US4916193A (en) * | 1987-12-17 | 1990-04-10 | Allied-Signal Inc. | Medical devices fabricated totally or in part from copolymers of recurring units derived from cyclic carbonates and lactides |
| US4916207A (en) * | 1987-12-17 | 1990-04-10 | Allied-Signal, Inc. | Polycarbonate homopolymer-based fiber compositions and method of melt-spinning same and device |
| US5274074A (en) * | 1987-12-17 | 1993-12-28 | United States Surgical Corporation | Medical devices fabricated from homopolymers and copolymers having recurring carbonate units |
| US5152781A (en) * | 1987-12-17 | 1992-10-06 | Allied-Signal Inc. | Medical devices fabricated from homopolymers and copolymers having recurring carbonate units |
| US4916209A (en) * | 1987-12-23 | 1990-04-10 | Pfizer Inc. | Bioabsorbable polydepsipeptide, preparation and use thereof |
| US4994551A (en) * | 1987-12-23 | 1991-02-19 | Pfizer Inc. | Bioabsorbable co-polydepsipeptide |
| US4838267A (en) * | 1988-02-12 | 1989-06-13 | Ethicon, Inc. | Glycolide/p-dioxanone block copolymers |
| US5092884A (en) * | 1988-03-24 | 1992-03-03 | American Cyanamid Company | Surgical composite structure having absorbable and nonabsorbable components |
| US4858601A (en) * | 1988-05-27 | 1989-08-22 | Glisson Richard R | Adjustable compression bone screw |
| US4944742A (en) * | 1988-06-06 | 1990-07-31 | Johnson & Johnson Orthopaedics, Inc. | Bone pin |
| US4858603A (en) * | 1988-06-06 | 1989-08-22 | Johnson & Johnson Orthopaedics, Inc. | Bone pin |
| US4990629A (en) * | 1989-01-03 | 1991-02-05 | Agency Of Industrial Science & Technology | Process for producing lactones |
| US5522817A (en) * | 1989-03-31 | 1996-06-04 | United States Surgical Corporation | Absorbable surgical fastener with bone penetrating elements |
| US5076807A (en) * | 1989-07-31 | 1991-12-31 | Ethicon, Inc. | Random copolymers of p-dioxanone, lactide and/or glycolide as coating polymers for surgical filaments |
| US5359831A (en) * | 1989-08-01 | 1994-11-01 | United States Surgical Corporation | Molded suture retainer |
| CA1337498C (en) * | 1989-09-01 | 1995-11-07 | Ephraim Broyer | Thermal treatment of thermoplastic filaments |
| US5294395A (en) * | 1989-09-01 | 1994-03-15 | Ethicon, Inc. | Thermal treatment of theraplastic filaments for the preparation of surgical sutures |
| US5451461A (en) * | 1989-09-01 | 1995-09-19 | Ethicon, Inc. | Thermal treatment of thermoplastic filaments for the preparation of surgical sutures |
| US5026589A (en) * | 1989-12-28 | 1991-06-25 | The Procter & Gamble Company | Disposable sanitary articles |
| US5047048A (en) * | 1990-01-30 | 1991-09-10 | Ethicon, Inc. | Crystalline copolymers of p-dioxanone and ε-caprolactone |
| US5007923A (en) * | 1990-01-31 | 1991-04-16 | Ethicon, Inc. | Crystalline copolyesters of amorphous (lactide/glycolide) and p-dioxanone |
| US5141522A (en) * | 1990-02-06 | 1992-08-25 | American Cyanamid Company | Composite material having absorbable and non-absorbable components for use with mammalian tissue |
| US5009663A (en) * | 1990-03-22 | 1991-04-23 | Brava Patient Och Invent Ab | Method for performing a surgical closure of a skin incision or wound and means for carrying out the method |
| US5019094A (en) * | 1990-05-09 | 1991-05-28 | Ethicon, Inc. | Crystalline copolymers of p-dioxanone and poly(alkylene oxides) |
| US5080665A (en) * | 1990-07-06 | 1992-01-14 | American Cyanamid Company | Deformable, absorbable surgical device |
| US5342395A (en) * | 1990-07-06 | 1994-08-30 | American Cyanamid Co. | Absorbable surgical repair devices |
| CA2049123C (en) * | 1990-09-13 | 2002-01-15 | David T. Green | Apparatus and method for subcuticular stapling of body tissue |
| US5389102A (en) * | 1990-09-13 | 1995-02-14 | United States Surgical Corporation | Apparatus and method for subcuticular stapling of body tissue |
| US5423856A (en) * | 1990-09-13 | 1995-06-13 | United States Surgical Corporation | Apparatus and method for subcuticular stapling of body tissue |
| US5201738A (en) * | 1990-12-10 | 1993-04-13 | Johnson & Johnson Orthopaedics, Inc. | Biodegradable biocompatible anti-displacement device for prosthetic bone joints |
| CA2060635A1 (en) * | 1991-02-12 | 1992-08-13 | Keith D'alessio | Bioabsorbable medical implants |
| US5264547A (en) * | 1991-04-12 | 1993-11-23 | Takasago International Corporation | Optically active ether lactone, optically active polymer thereof, and process for producing the polymer |
| US5502159A (en) * | 1991-04-17 | 1996-03-26 | United States Surgical Corporation | Absorbable composition |
| US5225520A (en) * | 1991-04-17 | 1993-07-06 | United States Surgical Corporation | Absorbable composition |
| US5314446A (en) * | 1992-02-19 | 1994-05-24 | Ethicon, Inc. | Sterilized heterogeneous braids |
| AU2234692A (en) * | 1992-06-05 | 1994-01-04 | Arch Development Corporation | Water and uv degradable lactic acid polymers |
| US5348026A (en) * | 1992-09-29 | 1994-09-20 | Smith & Nephew Richards Inc. | Osteoinductive bone screw |
| US5397816A (en) * | 1992-11-17 | 1995-03-14 | Ethicon, Inc. | Reinforced absorbable polymers |
| DE4243427C1 (en) * | 1992-12-15 | 1994-03-10 | Ethicon Gmbh | System for applying knots in surgical sutures |
| US6387363B1 (en) | 1992-12-31 | 2002-05-14 | United States Surgical Corporation | Biocompatible medical devices |
| US5468253A (en) † | 1993-01-21 | 1995-11-21 | Ethicon, Inc. | Elastomeric medical device |
| US5391768A (en) * | 1993-03-25 | 1995-02-21 | United States Surgical Corporation | Purification of 1,4-dioxan-2-one by crystallization |
| US8795332B2 (en) | 2002-09-30 | 2014-08-05 | Ethicon, Inc. | Barbed sutures |
| US5522841A (en) * | 1993-05-27 | 1996-06-04 | United States Surgical Corporation | Absorbable block copolymers and surgical articles fabricated therefrom |
| US5403347A (en) * | 1993-05-27 | 1995-04-04 | United States Surgical Corporation | Absorbable block copolymers and surgical articles fabricated therefrom |
| US6005019A (en) * | 1993-07-21 | 1999-12-21 | United States Surgical Corporation | Plasticizers for fibers used to form surgical devices |
| CA2127636C (en) * | 1993-07-21 | 2009-10-20 | Cheng-Kung Liu | Plasticizers for fibers used to form surgical devices |
| US5470340A (en) * | 1993-10-06 | 1995-11-28 | Ethicon, Inc. | Copolymers of (p-dioxanone/glycolide and/or lactide) and p-dioxanone |
| US5626811A (en) * | 1993-12-09 | 1997-05-06 | United States Surgical Corporation | Process of making a monofilament |
| US5391707A (en) * | 1993-12-10 | 1995-02-21 | United States Surgical Corporation | Process for the production of dioxanone |
| US5460592A (en) | 1994-01-24 | 1995-10-24 | Amersham Holdings, Inc. | Apparatus and method for making carrier assembly for radioactive seed carrier |
| US5442032A (en) * | 1994-03-15 | 1995-08-15 | Ethicon, Inc. | Copolymers of 1,4-dioxepan-2-one and 1,5,8,12-tetraoxacyclotetradecane-7-14-dione |
| US5611986A (en) * | 1994-07-05 | 1997-03-18 | Ethicon, Inc. | Medical devices containing high inherent viscosity poly(p-dioxanone) |
| US6339130B1 (en) * | 1994-07-22 | 2002-01-15 | United States Surgical Corporation | Bioabsorbable branched polymers containing units derived from dioxanone and medical/surgical devices manufactured therefrom |
| US20020032298A1 (en) * | 1994-07-22 | 2002-03-14 | Bennett Steven L. | Bioabsorbable branched polymers containing units derived from dioxanone and medical/surgical devices manufactured therefrom |
| US5578662A (en) | 1994-07-22 | 1996-11-26 | United States Surgical Corporation | Bioabsorbable branched polymers containing units derived from dioxanone and medical/surgical devices manufactured therefrom |
| US6206908B1 (en) | 1994-09-16 | 2001-03-27 | United States Surgical Corporation | Absorbable polymer and surgical articles fabricated therefrom |
| US5618313A (en) * | 1994-10-11 | 1997-04-08 | United States Surgical Corporation | Absorbable polymer and surgical articles fabricated therefrom |
| US6206897B1 (en) | 1994-12-02 | 2001-03-27 | Ethicon, Inc. | Enhanced visualization of the latching mechanism of latching surgical devices |
| US6100346A (en) * | 1995-03-06 | 2000-08-08 | Ethicon, Inc. | Copolymers of polyoxaamides |
| US5639851A (en) * | 1995-10-02 | 1997-06-17 | Ethicon, Inc. | High strength, melt processable, lactide-rich, poly(lactide-CO-P-dioxanone) copolymers |
| EP0786259B1 (en) | 1996-01-19 | 2004-03-31 | United States Surgical Corporation | Absorbable polymer blends and surgical articles fabricated therefrom |
| US5902599A (en) * | 1996-02-20 | 1999-05-11 | Massachusetts Institute Of Technology | Biodegradable polymer networks for use in orthopedic and dental applications |
| US5703200A (en) * | 1996-03-15 | 1997-12-30 | Ethicon, Inc. | Absorbable copolymers and blends of 6,6-dialkyl-1,4-dioxepan-2-one and its cyclic dimer |
| US6191236B1 (en) | 1996-10-11 | 2001-02-20 | United States Surgical Corporation | Bioabsorbable suture and method of its manufacture |
| US6648890B2 (en) | 1996-11-12 | 2003-11-18 | Triage Medical, Inc. | Bone fixation system with radially extendable anchor |
| US20050143734A1 (en) * | 1996-11-12 | 2005-06-30 | Cachia Victor V. | Bone fixation system with radially extendable anchor |
| US6632224B2 (en) * | 1996-11-12 | 2003-10-14 | Triage Medical, Inc. | Bone fixation system |
| US5893850A (en) | 1996-11-12 | 1999-04-13 | Cachia; Victor V. | Bone fixation device |
| WO2000049950A1 (en) | 1996-12-11 | 2000-08-31 | Ethicon, Inc. | Meniscal repair device having integral spring member |
| CA2224366C (en) | 1996-12-11 | 2006-10-31 | Ethicon, Inc. | Meniscal repair device |
| US8080058B2 (en) * | 2003-04-01 | 2011-12-20 | Depuy Mitek, Inc. | Method and apparatus for fixing a graft in a bone tunnel |
| US5931855A (en) | 1997-05-21 | 1999-08-03 | Frank Hoffman | Surgical methods using one-way suture |
| US6068920A (en) * | 1997-09-04 | 2000-05-30 | Mitsui Chemicals, Inc. | Random-block copolymer and monofilament thereof |
| US6007565A (en) * | 1997-09-05 | 1999-12-28 | United States Surgical | Absorbable block copolymers and surgical articles fabricated therefrom |
| US6277927B1 (en) | 1997-11-26 | 2001-08-21 | United States Surgical Corporation | Absorbable block copolymers and surgical articles fabricated therefrom |
| US6511748B1 (en) | 1998-01-06 | 2003-01-28 | Aderans Research Institute, Inc. | Bioabsorbable fibers and reinforced composites produced therefrom |
| US6494898B1 (en) | 1998-02-25 | 2002-12-17 | United States Surgical Corporation | Absorbable copolymers and surgical articles fabricated therefrom |
| US6165202A (en) * | 1998-07-06 | 2000-12-26 | United States Surgical Corporation | Absorbable polymers and surgical articles fabricated therefrom |
| US6235869B1 (en) | 1998-10-20 | 2001-05-22 | United States Surgical Corporation | Absorbable polymers and surgical articles fabricated therefrom |
| US6264674B1 (en) | 1998-11-09 | 2001-07-24 | Robert L. Washington | Process for hot stretching braided ligatures |
| US6884427B1 (en) * | 1999-02-08 | 2005-04-26 | Aderans Research Institute, Inc. | Filamentary means for introducing agents into tissue of a living host |
| EP2305324B1 (en) | 1999-03-25 | 2014-09-17 | Metabolix, Inc. | Medical devices and applications of polyhydroxyalkanoate polymers |
| DE60037577T2 (en) | 1999-04-09 | 2008-12-11 | Medi Physics, Inc., Arlington Heights | METHOD AND DEVICE FOR LOADING ADMINISTRATION SYSTEMS FOR BRACHYTHERAPIESEEDS |
| US6045571A (en) * | 1999-04-14 | 2000-04-04 | Ethicon, Inc. | Multifilament surgical cord |
| US6679824B1 (en) | 1999-04-28 | 2004-01-20 | Medi-Physics, Inc. | Products and methods for brachytherapy |
| US6368346B1 (en) | 1999-06-03 | 2002-04-09 | American Medical Systems, Inc. | Bioresorbable stent |
| KR20010010393A (en) | 1999-07-20 | 2001-02-05 | 김윤 | Biodegradable Block Copolymer of Hydrophobic and Hydrophilic Polymers, and Composition for Drug Delivery Comprising Same |
| US6448367B1 (en) * | 1999-09-13 | 2002-09-10 | Mitsui Chemicals, Inc. | Method of producing poly(p-dioxanone), poly (p-dioxanone) monofilaments and method for producing the same |
| US20040010286A1 (en) * | 2000-03-16 | 2004-01-15 | Gieringer Robert E. | Arthroscopic suture thread and method of use |
| JP2001288180A (en) * | 2000-03-31 | 2001-10-16 | Mitsui Chemicals Inc | PURIFIED beta-HYDROXY ETHOXYACETIC ACID SALT, METHOD FOR PRODUCING THE SAME, PURIFIED 2-p-DIOXANONE AND METHOD FOR PRODUCING THE SAME |
| AU2001279209B2 (en) * | 2000-08-08 | 2006-08-24 | Aderans Research Institute, Inc. | Scaffolds for tissue engineered hair |
| US6905455B2 (en) * | 2000-11-01 | 2005-06-14 | Medi-Physics, Inc. | Radioactive member and method of making |
| EP1545705A4 (en) | 2000-11-16 | 2010-04-28 | Microspherix Llc | Flexible and/or elastic brachytherapy seed or strand |
| CA2439114C (en) * | 2001-02-23 | 2009-10-27 | Ras Holding Corp | System for making incisions for scleral eye implants |
| US6511481B2 (en) * | 2001-03-30 | 2003-01-28 | Triage Medical, Inc. | Method and apparatus for fixation of proximal femoral fractures |
| US6887243B2 (en) | 2001-03-30 | 2005-05-03 | Triage Medical, Inc. | Method and apparatus for bone fixation with secondary compression |
| EP1387670B1 (en) * | 2001-05-11 | 2008-10-15 | Ortho-McNeil-Janssen Pharmaceuticals, Inc. | Immune modulation device for use in animals |
| US20030069629A1 (en) * | 2001-06-01 | 2003-04-10 | Jadhav Balkrishna S. | Bioresorbable medical devices |
| US20020188342A1 (en) * | 2001-06-01 | 2002-12-12 | Rykhus Robert L. | Short-term bioresorbable stents |
| US7056331B2 (en) * | 2001-06-29 | 2006-06-06 | Quill Medical, Inc. | Suture method |
| CA2459161A1 (en) | 2001-08-31 | 2003-03-13 | The Rockefeller University | Phosphodiesterase activity and regulation of phosphodiesterase 1b-mediated signaling in brain |
| US7029490B2 (en) | 2001-09-13 | 2006-04-18 | Arthrex, Inc. | High strength suture with coating and colored trace |
| US7060020B2 (en) * | 2001-11-02 | 2006-06-13 | Ideamatrix, Inc. | Delivery system and method for interstitial radiation therapy |
| US6761680B2 (en) * | 2001-11-02 | 2004-07-13 | Richard A. Terwilliger | Delivery system and method for interstitial radiation therapy using seed strands constructed with preformed strand housing |
| US6820318B2 (en) | 2001-11-02 | 2004-11-23 | Ideamatrix, Inc. | System for manufacturing interstitial radiation therapy seed strands |
| US6786858B2 (en) * | 2001-11-02 | 2004-09-07 | Ideamatrix, Inc. | Delivery system and method for interstitial radiotherapy using hollow seeds |
| US7074291B2 (en) | 2001-11-02 | 2006-07-11 | Worldwide Medical Technologies, L.L.C. | Delivery system and method for interstitial radiation therapy using strands constructed with extruded strand housings |
| US7094198B2 (en) | 2001-11-02 | 2006-08-22 | Worldwide Medical Technologies, Llc | Delivery system and method for interstitial radiation therapy using seed elements with ends having one of projections and indentations |
| US6685706B2 (en) * | 2001-11-19 | 2004-02-03 | Triage Medical, Inc. | Proximal anchors for bone fixation system |
| US7582097B2 (en) * | 2001-12-18 | 2009-09-01 | Ethicon, Inc. | Suture welding system and method |
| JP4508645B2 (en) | 2002-01-04 | 2010-07-21 | ザ ロックフェラー ユニバーシティー | Compositions and methods for the prevention and treatment of amyloid-beta peptide related diseases |
| US20040068284A1 (en) * | 2002-01-29 | 2004-04-08 | Barrows Thomas H. | Method for stimulating hair growth and kit for carrying out said method |
| US20040098049A1 (en) * | 2002-03-30 | 2004-05-20 | Jung-Nam Im | Monofilament suture and manufacturing method thereof |
| US20030236319A1 (en) * | 2002-06-25 | 2003-12-25 | Hye-Sung Yoon | Block copolymers for surgical articles |
| US6793678B2 (en) | 2002-06-27 | 2004-09-21 | Depuy Acromed, Inc. | Prosthetic intervertebral motion disc having dampening |
| AU2003261286B2 (en) | 2002-07-19 | 2009-10-29 | Interventional Spine, Inc. | Method and apparatus for spinal fixation |
| US6773450B2 (en) * | 2002-08-09 | 2004-08-10 | Quill Medical, Inc. | Suture anchor and method |
| US8100940B2 (en) | 2002-09-30 | 2012-01-24 | Quill Medical, Inc. | Barb configurations for barbed sutures |
| WO2004039857A1 (en) * | 2002-10-28 | 2004-05-13 | Tyco Healthcare Group Lp | Bioabsorbable adhesive compounds |
| US7771345B1 (en) * | 2002-12-03 | 2010-08-10 | O'donnell Pat D | Surgical instrument for treating female urinary stress incontinence |
| US6808486B1 (en) | 2002-12-03 | 2004-10-26 | Pat O'Donnell | Surgical instrument for treating female urinary stress incontinence |
| US7070601B2 (en) | 2003-01-16 | 2006-07-04 | Triage Medical, Inc. | Locking plate for bone anchors |
| US6951561B2 (en) | 2003-05-06 | 2005-10-04 | Triage Medical, Inc. | Spinal stabilization device |
| US6997862B2 (en) | 2003-05-13 | 2006-02-14 | Ideamatrix, Inc. | Delivery system and method for interstitial radiation therapy using seed strands with custom end spacing |
| CN1816369A (en) | 2003-07-02 | 2006-08-09 | 医疗物理有限公司 | Methods and systems of preparing preloaded needles for brachytherapy |
| US20050080314A1 (en) * | 2003-10-09 | 2005-04-14 | Terwilliger Richard A. | Shielded transport for multiple brachytheapy implants with integrated measuring and cutting board |
| WO2005039458A2 (en) * | 2003-10-23 | 2005-05-06 | Proxy Biomedical Limited | “a gastric constriction device” |
| US20050149030A1 (en) * | 2003-12-19 | 2005-07-07 | Depuy Spine, Inc. | Facet joint fixation system |
| US7597885B2 (en) * | 2004-03-26 | 2009-10-06 | Aderans Research Institute, Inc. | Tissue engineered biomimetic hair follicle graft |
| EP1737391A2 (en) * | 2004-04-13 | 2007-01-03 | Cook Incorporated | Implantable frame with variable compliance |
| CA2563347C (en) | 2004-04-20 | 2014-01-14 | Genzyme Corporation | Surgical mesh-like implant |
| SG164370A1 (en) | 2004-05-14 | 2010-09-29 | Quill Medical Inc | Suture methods and devices |
| US7862583B2 (en) * | 2004-05-27 | 2011-01-04 | Ethicon Endo-Surgery, Inc. | Fusible suture and method for suturing therewith |
| JP4674331B2 (en) * | 2004-06-04 | 2011-04-20 | 国立医薬品食品衛生研究所長 | Cell / tissue culture substrate and host embedded structure |
| WO2006002399A2 (en) * | 2004-06-24 | 2006-01-05 | Surmodics, Inc. | Biodegradable implantable medical devices, methods and systems |
| AR050212A1 (en) * | 2004-08-13 | 2006-10-04 | Aderans Res Inst Inc | ORGANOGENESIS FROM DISCELLED CELLS |
| WO2006026397A2 (en) * | 2004-08-26 | 2006-03-09 | Stout Medical Group, L.P. | Sutures and methods of making the same |
| US20060089672A1 (en) * | 2004-10-25 | 2006-04-27 | Jonathan Martinek | Yarns containing filaments made from shape memory alloys |
| US8298260B2 (en) * | 2004-11-29 | 2012-10-30 | Poly-Med, Inc. | Compliant, long-lasting absorbable monofilament sutures |
| US20070255294A1 (en) * | 2004-12-06 | 2007-11-01 | Wan-Seok Han | Medical Device with Enhanced Effect of Cell Regeneration and the Method Thereof |
| US20060147491A1 (en) * | 2005-01-05 | 2006-07-06 | Dewitt David M | Biodegradable coating compositions including multiple layers |
| US20060198868A1 (en) * | 2005-01-05 | 2006-09-07 | Dewitt David M | Biodegradable coating compositions comprising blends |
| US20060276882A1 (en) * | 2005-04-11 | 2006-12-07 | Cook Incorporated | Medical device including remodelable material attached to frame |
| DE102005029206A1 (en) * | 2005-06-22 | 2006-12-28 | Heraeus Kulzer Gmbh | Moldable implant material in the form of biodegradable/biocompatible or mono/poly filament thread, useful for filling wound cavities, having a circular loop and/or several circular loops, and at least three consecutive loops |
| US8187159B2 (en) | 2005-07-22 | 2012-05-29 | Biocompatibles, UK | Therapeutic member including a rail used in brachytherapy and other radiation therapy |
| US7736293B2 (en) | 2005-07-22 | 2010-06-15 | Biocompatibles Uk Limited | Implants for use in brachytherapy and other radiation therapy that resist migration and rotation |
| US8128552B2 (en) * | 2005-08-22 | 2012-03-06 | O'donnell Pat D | Surgical instrument for treating female pelvic prolapse |
| US8093420B2 (en) * | 2005-10-12 | 2012-01-10 | Bezwada Biomedical, Llc | Functionalized amino acids and absorbable polymers therefrom |
| WO2007053794A2 (en) | 2005-10-21 | 2007-05-10 | Bezwada Biomedical Llc | Functionalized phenolic compounds and absorbable therefrom |
| US20070122387A1 (en) * | 2005-11-22 | 2007-05-31 | Aderans Research Institute, Inc. | Hair grafts derived from plucked hair |
| WO2007062386A2 (en) * | 2005-11-22 | 2007-05-31 | Aderans Research Institute, Inc. | Hair follicle graft from tissue engineered skin |
| US8007526B2 (en) * | 2005-12-01 | 2011-08-30 | Bezwada Biomedical, Llc | Difunctionalized aromatic compounds and polymers therefrom |
| US7935843B2 (en) | 2005-12-09 | 2011-05-03 | Bezwada Biomedical, Llc | Functionalized diphenolics and absorbable polymers therefrom |
| US8236904B2 (en) * | 2005-12-28 | 2012-08-07 | Ethicon, Inc. | Bioabsorbable polymer compositions exhibiting enhanced crystallization and hydrolysis rates |
| AU2007201213A1 (en) * | 2006-04-06 | 2007-10-25 | Tyco Healthcare Group Lp | Yarns containing thermoplastic elastomer copolymer and polyolefin filaments |
| US7988611B2 (en) | 2006-05-09 | 2011-08-02 | Biocompatibles Uk Limited | After-loader for positioning implants for needle delivery in brachytherapy and other radiation therapy |
| US20070265487A1 (en) * | 2006-05-09 | 2007-11-15 | Worldwide Medical Technologies Llc | Applicators for use in positioning implants for use in brachytherapy and other radiation therapy |
| US8771162B2 (en) | 2010-04-23 | 2014-07-08 | Eckert & Ziegler Bebig S. A. | Spacers for use in brachytherapy, radiotherapy, and other medical therapy |
| US8367108B2 (en) | 2006-09-01 | 2013-02-05 | Bezwada Biomedical, Llc | Functionalized non-phenolic amino acids and absorbable polymers therefrom |
| US7878964B1 (en) | 2006-09-07 | 2011-02-01 | Biocompatibles Uk Limited | Echogenic spacers and strands |
| US7874976B1 (en) | 2006-09-07 | 2011-01-25 | Biocompatibles Uk Limited | Echogenic strands and spacers therein |
| US8105382B2 (en) | 2006-12-07 | 2012-01-31 | Interventional Spine, Inc. | Intervertebral implant |
| US20080221618A1 (en) * | 2007-03-09 | 2008-09-11 | Gaoyuan Chen | Co-extruded tissue grasping monofilament |
| US20080255612A1 (en) | 2007-04-13 | 2008-10-16 | Angiotech Pharmaceuticals, Inc. | Self-retaining systems for surgical procedures |
| US7998176B2 (en) | 2007-06-08 | 2011-08-16 | Interventional Spine, Inc. | Method and apparatus for spinal stabilization |
| US7985537B2 (en) * | 2007-06-12 | 2011-07-26 | Aderans Research Institute, Inc. | Methods for determining the hair follicle inductive properties of a composition |
| US8900307B2 (en) | 2007-06-26 | 2014-12-02 | DePuy Synthes Products, LLC | Highly lordosed fusion cage |
| US20090004243A1 (en) | 2007-06-29 | 2009-01-01 | Pacetti Stephen D | Biodegradable triblock copolymers for implantable devices |
| US8217134B2 (en) | 2007-08-30 | 2012-07-10 | Bezwada Biomedical, Llc | Controlled release of biologically active compounds |
| US8048980B2 (en) | 2007-09-17 | 2011-11-01 | Bezwada Biomedical, Llc | Hydrolysable linkers and cross-linkers for absorbable polymers |
| WO2009042841A2 (en) | 2007-09-27 | 2009-04-02 | Angiotech Pharmaceuticals, Inc. | Self-retaining sutures including tissue retainers having improved strength |
| US8500947B2 (en) * | 2007-11-15 | 2013-08-06 | Covidien Lp | Speeding cure rate of bioadhesives |
| US8916077B1 (en) | 2007-12-19 | 2014-12-23 | Ethicon, Inc. | Self-retaining sutures with retainers formed from molten material |
| EP2222233B1 (en) | 2007-12-19 | 2020-03-25 | Ethicon, LLC | Self-retaining sutures with heat-contact mediated retainers |
| US8118834B1 (en) | 2007-12-20 | 2012-02-21 | Angiotech Pharmaceuticals, Inc. | Composite self-retaining sutures and method |
| EP2471493A1 (en) | 2008-01-17 | 2012-07-04 | Synthes GmbH | An expandable intervertebral implant and associated method of manufacturing the same |
| ES2602570T3 (en) | 2008-01-30 | 2017-02-21 | Ethicon Llc | Apparatus and method for forming self-retaining sutures |
| EP2249712B8 (en) | 2008-02-21 | 2018-12-26 | Ethicon LLC | Method and apparatus for elevating retainers on self-retaining sutures |
| US8641732B1 (en) | 2008-02-26 | 2014-02-04 | Ethicon, Inc. | Self-retaining suture with variable dimension filament and method |
| BRPI0910325A8 (en) | 2008-04-05 | 2019-01-29 | Synthes Gmbh | expandable intervertebral implant |
| CN102056552B (en) | 2008-04-15 | 2013-07-03 | 伊西康有限责任公司 | Self-retaining sutures with bi-directional retainers or uni-directional retainers |
| US20090275963A1 (en) * | 2008-05-01 | 2009-11-05 | May Thomas C | High-Strength Suture With Absorbable Components |
| US8309132B2 (en) * | 2008-05-16 | 2012-11-13 | Bezwada Biomedical, Llc | Bioabsorbable polyesteramides and uses thereof |
| US8269025B2 (en) | 2008-07-03 | 2012-09-18 | Tyco Healthcare Group Lp | Purification of p-dioxanone |
| MX339174B (en) | 2008-11-03 | 2016-05-12 | Ethicon Llc | Length of self-retaining suture and method and device for using the same. |
| JP2010232895A (en) * | 2009-03-26 | 2010-10-14 | Fuji Xerox Co Ltd | Communication controller and information processor |
| US9526620B2 (en) | 2009-03-30 | 2016-12-27 | DePuy Synthes Products, Inc. | Zero profile spinal fusion cage |
| US9393129B2 (en) | 2009-12-10 | 2016-07-19 | DePuy Synthes Products, Inc. | Bellows-like expandable interbody fusion cage |
| WO2011090628A2 (en) | 2009-12-29 | 2011-07-28 | Angiotech Pharmaceuticals, Inc. | Bidirectional self-retaining sutures with laser-marked and/or non-laser marked indicia and methods |
| US20110238094A1 (en) * | 2010-03-25 | 2011-09-29 | Thomas Jonathan D | Hernia Patch |
| CA2798373C (en) | 2010-05-04 | 2018-10-23 | Ethicon, Llc | Self-retaining systems having laser-cut retainers |
| EP3155978B1 (en) | 2010-06-11 | 2022-04-13 | Cilag GmbH International | Suture delivery tools for endoscopic and robot-assisted surgery |
| US9282979B2 (en) | 2010-06-24 | 2016-03-15 | DePuy Synthes Products, Inc. | Instruments and methods for non-parallel disc space preparation |
| US8979860B2 (en) | 2010-06-24 | 2015-03-17 | DePuy Synthes Products. LLC | Enhanced cage insertion device |
| EP2588034B1 (en) | 2010-06-29 | 2018-01-03 | Synthes GmbH | Distractible intervertebral implant |
| US9402732B2 (en) | 2010-10-11 | 2016-08-02 | DePuy Synthes Products, Inc. | Expandable interspinous process spacer implant |
| WO2012061658A2 (en) | 2010-11-03 | 2012-05-10 | Angiotech Pharmaceuticals, Inc. | Drug-eluting self-retaining sutures and methods relating thereto |
| US9675341B2 (en) | 2010-11-09 | 2017-06-13 | Ethicon Inc. | Emergency self-retaining sutures and packaging |
| US9161751B2 (en) | 2010-12-02 | 2015-10-20 | Coloplast A/S | Suture system and assembly |
| US9220495B2 (en) * | 2011-02-10 | 2015-12-29 | Coloplast A/S | Suture system and assembly including a suture clip |
| JP6125488B2 (en) | 2011-03-23 | 2017-05-10 | エシコン・エルエルシーＥｔｈｉｃｏｎ ＬＬＣ | Self-holding variable loop suture |
| US20130172931A1 (en) | 2011-06-06 | 2013-07-04 | Jeffrey M. Gross | Methods and devices for soft palate tissue elevation procedures |
| US8597318B2 (en) | 2011-08-08 | 2013-12-03 | Refocus Group, Inc. | Apparatus and method for forming incisions in ocular tissue |
| JP4987149B1 (en) * | 2011-08-10 | 2012-07-25 | 株式会社トラストレックス | acupuncture |
| US10940167B2 (en) | 2012-02-10 | 2021-03-09 | Cvdevices, Llc | Methods and uses of biological tissues for various stent and other medical applications |
| DE102012206400A1 (en) * | 2012-04-18 | 2013-10-24 | Itv Denkendorf Produktservice Gmbh | Composition, body, thread, medical kit and medical product with improved degradation profile |
| US8940052B2 (en) | 2012-07-26 | 2015-01-27 | DePuy Synthes Products, LLC | Expandable implant |
| US20140067069A1 (en) | 2012-08-30 | 2014-03-06 | Interventional Spine, Inc. | Artificial disc |
| WO2014039995A1 (en) | 2012-09-07 | 2014-03-13 | Fibrocell Technologies, Inc. | Fibroblast compositions for treating cardial damage after an infarct |
| AU2014214700B2 (en) | 2013-02-11 | 2018-01-18 | Cook Medical Technologies Llc | Expandable support frame and medical device |
| US9522070B2 (en) | 2013-03-07 | 2016-12-20 | Interventional Spine, Inc. | Intervertebral implant |
| US9522028B2 (en) | 2013-07-03 | 2016-12-20 | Interventional Spine, Inc. | Method and apparatus for sacroiliac joint fixation |
| US9259514B2 (en) | 2013-12-18 | 2016-02-16 | Ethicon, Inc. | Absorbable polymeric blend compositions based on copolymers prepared from mono- and di-functional polymerization initiators, processing methods, and medical devices therefrom |
| SI3230463T1 (en) | 2014-12-09 | 2023-01-31 | Sweetwater Energy, Inc. | Rapid pretreatment |
| US11426290B2 (en) | 2015-03-06 | 2022-08-30 | DePuy Synthes Products, Inc. | Expandable intervertebral implant, system, kit and method |
| US9913727B2 (en) | 2015-07-02 | 2018-03-13 | Medos International Sarl | Expandable implant |
| US11510788B2 (en) | 2016-06-28 | 2022-11-29 | Eit Emerging Implant Technologies Gmbh | Expandable, angularly adjustable intervertebral cages |
| US11596522B2 (en) | 2016-06-28 | 2023-03-07 | Eit Emerging Implant Technologies Gmbh | Expandable and angularly adjustable intervertebral cages with articulating joint |
| US10537436B2 (en) | 2016-11-01 | 2020-01-21 | DePuy Synthes Products, Inc. | Curved expandable cage |
| US10888433B2 (en) | 2016-12-14 | 2021-01-12 | DePuy Synthes Products, Inc. | Intervertebral implant inserter and related methods |
| WO2018151833A1 (en) | 2017-02-16 | 2018-08-23 | Sweetwater Energy, Inc. | High pressure zone formation for pretreatment |
| US10398563B2 (en) | 2017-05-08 | 2019-09-03 | Medos International Sarl | Expandable cage |
| US11344424B2 (en) | 2017-06-14 | 2022-05-31 | Medos International Sarl | Expandable intervertebral implant and related methods |
| US10940016B2 (en) | 2017-07-05 | 2021-03-09 | Medos International Sarl | Expandable intervertebral fusion cage |
| WO2019040302A1 (en) | 2017-08-23 | 2019-02-28 | Refocus Group, Inc. | Surgical tool for forming incisions in ocular tissue with tip providing visibility and related apparatus and method |
| US11446156B2 (en) | 2018-10-25 | 2022-09-20 | Medos International Sarl | Expandable intervertebral implant, inserter instrument, and related methods |
| US11028222B2 (en) | 2018-11-28 | 2021-06-08 | Ethicon, Inc. | Advanced processing of absorbable poly(p-dioxanone) containing high level of p-dioxanone monomer |
| CN110075366A (en) * | 2019-04-01 | 2019-08-02 | 杨青青 | A kind of anti-oxidant lifting esthetic line of biological absorbable and its preparation method and application |
| EP4077490A1 (en) | 2019-12-22 | 2022-10-26 | Sweetwater Energy, Inc. | Methods of making specialized lignin and lignin products from biomass |
| US11426286B2 (en) | 2020-03-06 | 2022-08-30 | Eit Emerging Implant Technologies Gmbh | Expandable intervertebral implant |
| US11850160B2 (en) | 2021-03-26 | 2023-12-26 | Medos International Sarl | Expandable lordotic intervertebral fusion cage |
| US11752009B2 (en) | 2021-04-06 | 2023-09-12 | Medos International Sarl | Expandable intervertebral fusion cage |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3063967A (en) * | 1959-10-07 | 1962-11-13 | Gen Aniline & Film Corp | Polymers of 2-p-dioxanone and method for making same |
| US3190858A (en) * | 1959-12-03 | 1965-06-22 | Union Carbide Corp | Polymerization of cyclic esters |
| US3063968A (en) * | 1960-06-15 | 1962-11-13 | Gen Aniline & Film Corp | Polymerization of 2-p-dioxanone |
| US3297033A (en) * | 1963-10-31 | 1967-01-10 | American Cyanamid Co | Surgical sutures |
| US3645941A (en) * | 1970-04-01 | 1972-02-29 | Eastman Kodak Co | Method of preparing 2-p-dioxanone polymers |
| BE758156R (en) * | 1970-05-13 | 1971-04-28 | Ethicon Inc | ABSORBABLE SUTURE ELEMENT AND ITS |
| US3867190A (en) * | 1971-10-18 | 1975-02-18 | American Cyanamid Co | Reducing capillarity of polyglycolic acid sutures |
| US3960152A (en) * | 1974-01-21 | 1976-06-01 | American Cyanamid Company | Surgical sutures of unsymmetrically substituted 1,4-dioxane-2,5-diones |
-
1976
- 1976-01-12 US US05/648,236 patent/US4052988A/en not_active Expired - Lifetime
- 1976-12-14 IN IN2195/CAL/76A patent/IN145409B/en unknown
- 1976-12-20 GR GR52444A patent/GR60784B/en unknown
-
1977
- 1977-01-07 FR FR7700376A patent/FR2357234A1/en active Granted
- 1977-01-07 AU AU21168/77A patent/AU506167B2/en not_active Expired
- 1977-01-10 JP JP52000895A patent/JPS6036785B2/en not_active Expired
- 1977-01-10 BE BE173971A patent/BE850247A/en not_active IP Right Cessation
- 1977-01-10 IT IT47573/77A patent/IT1086656B/en active
- 1977-01-10 CA CA269,401A patent/CA1124943A/en not_active Expired
- 1977-01-10 CH CH24677A patent/CH637835A5/en not_active IP Right Cessation
- 1977-01-10 DE DE2700729A patent/DE2700729C2/en not_active Expired
- 1977-01-10 TR TR19478A patent/TR19478A/en unknown
- 1977-01-11 AT AT9377A patent/AT352898B/en not_active IP Right Cessation
- 1977-01-11 BR BR7700141A patent/BR7700141A/en unknown
- 1977-01-11 ZA ZA00770124A patent/ZA77124B/en unknown
- 1977-01-11 NL NLAANVRAGE7700216,A patent/NL185350C/en not_active IP Right Cessation
- 1977-01-11 SE SE7700214A patent/SE445297B/en not_active IP Right Cessation
- 1977-01-11 IL IL51240A patent/IL51240A/en unknown
- 1977-01-11 GB GB933/77A patent/GB1540053A/en not_active Expired
- 1977-01-12 PL PL19526877A patent/PL195268A1/en unknown
- 1977-01-12 PT PT66060A patent/PT66060B/en unknown
- 1977-06-06 FR FR7717201A patent/FR2361092A1/en active Granted
-
1981
- 1981-04-21 CH CH261381A patent/CH637834A5/en not_active IP Right Cessation
-
1985
- 1985-02-01 JP JP60016700A patent/JPS60185562A/en active Granted
-
1986
- 1986-01-03 SE SE8600027A patent/SE448205B/en not_active IP Right Cessation
- 1986-01-09 SE SE8600096A patent/SE448206B/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1124943A (en) | Synthetic absorbable surgical devices of poly-dioxanone | |
| US4441496A (en) | Copolymers of p-dioxanone and 2,5-morpholinediones and surgical devices formed therefrom having accelerated absorption characteristics | |
| US4141087A (en) | Isomorphic copolyoxalates and sutures thereof | |
| US4205399A (en) | Synthetic absorbable surgical devices of poly(alkylene oxalates) | |
| CA1112795A (en) | Synthetic absorbable surgical devices of poly(alkylene oxalates) | |
| US4137921A (en) | Addition copolymers of lactide and glycolide and method of preparation | |
| US3736646A (en) | Method of attaching surgical needles to multifilament polyglycolic acid absorbable sutures | |
| JP5280839B2 (en) | Absorbable / biodegradable composite yarn and property-adjusting surgical implant formed therefrom | |
| US4033938A (en) | Polymers of unsymmetrically substituted 1,4-dioxane-2,5-diones | |
| US3867190A (en) | Reducing capillarity of polyglycolic acid sutures | |
| US5854383A (en) | Aliphatic polyesters of trimethylene carbonate epsilon-caprolactone and glycolide | |
| US3960152A (en) | Surgical sutures of unsymmetrically substituted 1,4-dioxane-2,5-diones | |
| US3982543A (en) | Reducing capillarity of polyglycolic acid sutures | |
| CA1123984A (en) | Block copolymers of lactide and glycolide and surgical prosthesis therefrom | |
| US3797499A (en) | Polylactide fabric graphs for surgical implantation | |
| US4838267A (en) | Glycolide/p-dioxanone block copolymers | |
| US4605730A (en) | Surgical articles of copolymers of glycolide and ε-caprolactone and methods of producing the same | |
| US3636956A (en) | Polylactide sutures | |
| US5152781A (en) | Medical devices fabricated from homopolymers and copolymers having recurring carbonate units | |
| US5145945A (en) | Homopolymers and copolymers having recurring carbonate units | |
| JPH0912689A (en) | High-strength, rapidly absorbable and melt processable poly(glycolide-co-para-dioxanone) copolymer having high glycolide content | |
| US5256764A (en) | Medical devices fabricated from homopolymers and copolymers having recurring carbonate units | |
| US6048947A (en) | Triblock terpolymer, its use for surgical suture material and process for its production | |
| JP3253222B2 (en) | Copolymer of p-dioxanone | |
| US6500193B1 (en) | Sutures |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |